<SEC-DOCUMENT>0001193125-23-182040.txt : 20230705
<SEC-HEADER>0001193125-23-182040.hdr.sgml : 20230705
<ACCEPTANCE-DATETIME>20230705171459
ACCESSION NUMBER:		0001193125-23-182040
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20230628
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230705
DATE AS OF CHANGE:		20230705

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Acadia Healthcare Company, Inc.
		CENTRAL INDEX KEY:			0001520697
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35331
		FILM NUMBER:		231070567

	BUSINESS ADDRESS:	
		STREET 1:		6100 TOWER CIRCLE
		STREET 2:		SUITE 1000
		CITY:			FRANKLIN
		STATE:			TN
		ZIP:			37067
		BUSINESS PHONE:		615-861-6000

	MAIL ADDRESS:	
		STREET 1:		6100 TOWER CIRCLE
		STREET 2:		SUITE 1000
		CITY:			FRANKLIN
		STATE:			TN
		ZIP:			37067
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d434500d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:achc="http://www.acadiahealthcare.com/20230628" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2023-06-28_to_2023-06-28">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2023-06-28_to_2023-06-28">0001520697</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:type="simple" xlink:href="achc-20230628.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef> </ix:references> <ix:resources> <xbrli:context id="duration_2023-06-28_to_2023-06-28"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-06-28</xbrli:startDate> <xbrli:endDate>2023-06-28</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">WASHINGTON, DC 20549</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2023-06-28_to_2023-06-28">8-K</ix:nonNumeric></span></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">PURSUANT TO SECTION 13 OR 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">OF THE SECURITIES EXCHANGE ACT OF 1934</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of report (Date of earliest event reported): July&#160;5, 2023 (<ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2023-06-28_to_2023-06-28" format="ixt:datemonthdayyearen">June 28, 2023</ix:nonNumeric>)</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="duration_2023-06-28_to_2023-06-28">Acadia Healthcare Company, Inc.</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact Name of Registrant as Specified in Its Charter)</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2023-06-28_to_2023-06-28" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2023-06-28_to_2023-06-28">001-35331</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2023-06-28_to_2023-06-28">45-2492228</ix:nonNumeric></span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(State or Other Jurisdiction<br />of Incorporation)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Commission<br />File Number)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(IRS Employer<br />Identification No.)</span></td></tr></table> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:50%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:48%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2023-06-28_to_2023-06-28">6100 Tower Circle</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressAddressLine2" contextRef="duration_2023-06-28_to_2023-06-28">Suite 1000</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2023-06-28_to_2023-06-28">Franklin</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2023-06-28_to_2023-06-28" format="ixt-sec:stateprovnameen">Tennessee</ix:nonNumeric></p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:bottom"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2023-06-28_to_2023-06-28">37067</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Address of Principal Executive Offices)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Zip Code)</span></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2023-06-28_to_2023-06-28">(615)</ix:nonNumeric> <span style="white-space:nowrap"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2023-06-28_to_2023-06-28">861-6000</ix:nonNumeric></span></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Registrant&#8217;s Telephone Number, including Area Code)</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Not Applicable</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former Name or Former Address, if Changed Since Last Report)</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (See General Instruction A.2. below):</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2023-06-28_to_2023-06-28" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2023-06-28_to_2023-06-28" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2023-06-28_to_2023-06-28" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2023-06-28_to_2023-06-28" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section&#160;12(b) of the Act:</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading<br />Symbol</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange<br />on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2023-06-28_to_2023-06-28">Common Stock, $0.01 par value</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2023-06-28_to_2023-06-28">ACHC</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2023-06-28_to_2023-06-28" format="ixt-sec:exchnameen">NASDAQ Global Select Market</ix:nonNumeric></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 <span style="white-space:nowrap">(&#167;240.12b-2</span> of this chapter).</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:right">Emerging growth company&#160;&#160;<ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2023-06-28_to_2023-06-28" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#160;&#160;&#9744;</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;5.02</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Appointment of Brian Farley as Executive Vice President and General Counsel </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On June&#160;30, 2023, Acadia Healthcare Company, Inc. (the &#8220;Company&#8221;) appointed Brian Farley as the Executive Vice President and General Counsel of the Company, effective July&#160;26, 2023. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Mr.&#160;Farley joins the Company from GoHealth, Inc. (NASDAQ: GOCO) (&#8220;GoHealth&#8221;), a health insurance marketplace and technology company, where he has served as Chief Legal Officer and Corporate Secretary since June 2020. Prior to joining GoHealth, Mr.&#160;Farley served in various roles at Veradigm Inc. (formerly known as Allscripts Healthcare Solutions, Inc.) (NASDAQ: MDRX), a healthcare technology company, including most recently as Executive Vice President, General Counsel and Chief Administrative Officer from May 2013 to June 2020. He also served in various positions, including as Corporate Vice President and General Counsel, at Motorola Mobility LLC, a provider of mobile communication devices and video and data delivery solutions, from 2005 to 2013. Mr.&#160;Farley received a Bachelor of Arts in Political Economics from Colorado College, a Juris Doctor from The George Washington University National Law Center and an Executive Master&#8217;s in Business Administration from the University of Colorado. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There are no arrangements or understandings between Mr.&#160;Farley and any other person pursuant to which Mr.&#160;Farley was appointed as Executive Vice President and General Counsel, and there are no family relationships among any of the Company&#8217;s directors or executive officers and Mr.&#160;Farley. Mr.&#160;Farley does not have any direct or indirect material interest in any transaction or proposed transaction required to be reported under Item 404(a)&#160;of Regulation <span style="white-space:nowrap">S-K.</span> </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Chris Howard Retirement </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Chris Howard, currently Executive Vice President, General Counsel and Secretary, will retire from his position effective July&#160;26, 2023. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On July&#160;5, 2023, in connection with his retirement from the Company, the Company entered into a separation and transition agreement (the &#8220;Howard Separation and Transition Agreement&#8221;) with Mr.&#160;Howard. Under this Agreement, the Company and Mr.&#160;Howard have agreed that Mr.&#160;Howard will continue to serve as Executive Vice President, General Counsel and Secretary through July&#160;26, 2023 and will subsequently continue to be employed by the Company and provide transition advisory services to the Company&#8217;s Chief Executive Officer and General Counsel through July&#160;31, 2023. Following his separation until February&#160;24, 2024 (the &#8220;Howard Transition Period&#8221;), Mr.&#160;Howard will make himself available to provide transition services to the Company&#8217;s Chief Executive Officer, General Counsel, and Chief Human Resources Officer. In exchange for these services, the Company has agreed to provide Mr.&#160;Howard a monthly fee during the Howard Transition Period of $10,591.88 and permits Mr.&#160;Howard to remain eligible to earn performance-based equity awards granted to him in 2021 for which the performance period ends on December&#160;31, 2023. Due to Mr.&#160;Howard&#8217;s ongoing involvement with the Company and the consideration provided by the Company, the parties have further agreed that Mr.&#160;Howard&#8217;s <span style="white-space:nowrap">non-competition</span> and employee <span style="white-space:nowrap">non-solicitation</span> covenant will be extended through the second anniversary of the expiration of the Howard Transition Period. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The foregoing description of the Howard Separation and Transition Agreement does not purport to be complete and is subject to, and qualified in its entirety by, the full text of the Howard Separation Agreement, a copy of which is attached hereto as Exhibit 10.1. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">David Duckworth Departure </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As previously disclosed, on June&#160;1, 2023, the Company announced that David Duckworth will resign as Chief Financial Officer, effective July&#160;10, 2023. </p> <p style="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&#160;</p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On July&#160;5, 2023, in connection with his departure from the Company, the Company entered into a transition agreement (the &#8220;Duckworth Transition Agreement&#8221;) with Mr.&#160;Duckworth. Under this Agreement, the Company and Mr.&#160;Duckworth have agreed that Mr.&#160;Duckworth will continue to serve as Chief Financial Officer through July&#160;9, 2023 and will subsequently continue to be employed by the Company and provide transition advisory services to the Company&#8217;s Chief Executive Officer and new Chief Financial Officer through July&#160;31, 2023. Following Mr.&#160;Duckworth&#8217;s separation from employment through the date on which the Company files with the U.S. Securities and Exchange Commission its annual report on Form <span style="white-space:nowrap">10-K</span> with respect to the fiscal year ending December&#160;31, 2023 (the &#8220;Duckworth Transition Period&#8221;), Mr.&#160;Duckworth will make himself available to provide transition services to the Company&#8217;s Chief Executive Officer and Chief Financial Officer. In exchange for these services, the Company has agreed to provide Mr.&#160;Duckworth a monthly fee during the Duckworth Transition Period of $11,574.89 and permits Mr.&#160;Duckworth to remain eligible to earn performance-based equity awards granted to him in 2021 for which the performance period ends on December&#160;31, 2023. Due to Mr.&#160;Duckworth&#8217;s ongoing involvement with the Company and the consideration provided by the Company, the parties have further agreed that Mr.&#160;Duckworth&#8217;s <span style="white-space:nowrap">non-competition</span> will be extended through the first anniversary of the expiration of the Duckworth Transition Period. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The foregoing description of the Duckworth Transition Agreement does not purport to be complete and is subject to, and qualified in its entirety by, the full text of the Duckworth Transition Agreement, a copy of which is attached hereto as Exhibit 10.2. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Larry Harrod Retirement </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As previously disclosed, on June&#160;1, 2023, the Company announced that Larry Harrod resigned as Executive Vice President of Finance, effective June&#160;30, 2023. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On June&#160;28, 2023, in connection with his departure from the Company, the Company entered into a separation and consulting agreement (the &#8220;Harrod Separation and Consulting Agreement&#8221;) with Mr.&#160;Harrod. Pursuant to the Harrod Separation and Consulting Agreement, Mr.&#160;Harrod will make himself available to provide transition advisory services during the period immediately following Mr.&#160;Harrod&#8217;s resignation and ending on December&#160;31, 2023 in exchange for a monthly payment of $10,309.87. In addition, Mr.&#160;Harrod will remain eligible to earn an annual cash bonus for the 2023 performance year, determined based on actual performance achievement, as determined by the Board or the Compensation Committee in its sole discretion, which amount shall be prorated based on the actual number of days elapsed during the 2023 calendar year prior to Mr.&#160;Harrod&#8217;s resignation. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The foregoing description of the Harrod Separation and Consulting Agreement does not purport to be complete and is subject to, and qualified in its entirety by, the full text of the Harrod Separation and Consulting Agreement, a copy of which is attached hereto as Exhibit 10.3. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;9.01.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Exhibits </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td></td>

<td style="vertical-align:bottom;width:4%"></td>
<td style="width:93%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Exhibit<br />No.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman;font-weight:bold">Description</p></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d434500dex101.htm">Separation and Transition Agreement, dated July&#160;5, between Acadia Management Company, LLC. and Chris Howard </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.2</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d434500dex102.htm">Transition Agreement, dated July&#160;5, 2023, by and between Acadia Management Company, LLC and David Duckworth </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.3</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d434500dex103.htm">Separation and Consulting Agreement, dated June&#160;28, between Acadia Management Company, LLC and Laurence Harrod </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL document)</td></tr>
</table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURE </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:45%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:4%"></td>

<td style="vertical-align:bottom"></td>
<td style="width:3%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:45%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">Date: July&#160;5, 2023</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" colspan="3"><span style="font-weight:bold">ACADIA HEALTHCARE COMPANY, INC.</span></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Christopher L. Howard</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Christopher L. Howard</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Executive Vice President, Secretary and General Counsel</td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>d434500dex101.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B></B><B><I>Execution Version</I></B><B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>SEPARATION AND TRANSITION AGREEMENT </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Separation Agreement (this &#147;<U>Agreement</U>&#148;), dated July&nbsp;5, 2023, is effective as of the &#147;Effective Date&#148; (as
defined below), between Acadia Management Company, LLC (the &#147;<U>Company</U>&#148;) and Chris Howard (&#147;<U>Employee</U>&#148;), and for the purposes of Section&nbsp;3 only, Acadia Healthcare Company, Inc. (&#147;<U>Acadia</U>&#148; and with
the Company and Employee, collectively, the &#147;<U>Parties</U>&#148;). </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>W</U> <U>I</U> <U>T</U> <U>N</U> <U>E</U> <U>S</U> <U>S</U>
<U>E</U> <U>T</U> <U>H</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, Employee is employed by the Company pursuant to an Amended and Restated Employment Agreement, dated
April&nbsp;7, 2014, between the Company and Employee (the &#147;<U>Employment Agreement</U>&#148;); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, Employee is resigning as
Executive Vice President, General Counsel and Secretary of the Company on the General Counsel Resignation Date (as defined below), after which date, Employee will continue to be employed by the Company as an advisor until the Employment Separation
Date (as defined below), after which date, Employee shall provide Consulting Advisory Service (as defined below) to the Company as provided under this Agreement; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Parties wish to resolve all matters that Employee may have related to Employee&#146;s employment and the termination of
Employee&#146;s employment and consulting services. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NOW, THEREFORE, in consideration of the premises and the releases, representations,
covenants and obligations herein contained (including the exhibits hereto), the Parties, intending to be legally bound, hereby agree as follows: </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.&nbsp;&nbsp;&nbsp;&nbsp;<B><U>General Counsel Resignation; Cessation of Employment Relationship; Final Pay; COBRA</U></B>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;Employee shall continue to serve as Executive Vice President, General Counsel and Secretary of the Company until
July&nbsp;26, 2023 or such earlier date as determined by the Company in its sole discretion (the &#147;<U>General Counsel Resignation Date</U>&#148;), upon which date Employee shall resign, and shall be automatically deemed to have resigned without
the requirement of any further action, from his position as Executive Vice President, General Counsel and Secretary of the Company. Following the General Counsel Resignation Date, the Company shall continue to employ Employee as an advisor until
July&nbsp;31, 2023 or such earlier date as determined by the Company in its sole discretion (the &#147;<U>Employment Separation Date</U>&#148;), upon which date Employee shall promptly resign, and shall be deemed to have resigned without the
requirement of any further action, from such advisor position and any other positions at the Company and its affiliates (whether as an employee, officer, director, member of any board of directors and/or fiduciary or otherwise). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;Between the Effective Date and the Employment Separation Date (the &#147;<U>Transition Period</U>&#148;), Employee
agrees that the Company may reduce or eliminate some or all of Employee&#146;s duties, authorities and responsibilities in such manner and at such time or times as it determines to be appropriate in its sole discretion without constituting a
constructive termination </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
or breach of any agreement with Employee. From the Effective Date until the General Counsel Resignation Date (the &#147;<U>Continued GC Service Period</U>&#148;), subject to the prior sentence,
Employee will continue to perform Employee&#146;s duties as Executive Vice President, General Counsel and Secretary of the Company in a manner consistent with past practice, as well as such additional transition duties as may be reasonably requested
by the Company to facilitate a smooth transition of Employee&#146;s job responsibilities to his successor. During the period following the General Counsel Resignation Date and ending on the Employment Separation Date (the &#147;<U>Employee Advisory
Service Period</U>&#148;) Employee shall continue to be employed by the Company and shall provide transition advisory services as reasonably requested by the Company&#146;s new Executive Vice President and General Counsel, the Company&#146;s Chief
Human Resources Officer, the Company&#146;s Chief Executive Officer or the Board of Acadia. During the Transition Period, Employee shall be in conformance and comply with the Employment Agreement and all Company written or established policies,
rules and regulations governing the conduct of its employees, now in effect, or as subsequently adopted or amended. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;The Employment Separation Date will be the termination date of Employee&#146;s employment for purposes of
Employee&#146;s active participation in and coverage under all benefit plans and programs sponsored by or through the Company or its affiliates, except as otherwise provided for in Section&nbsp;4(f) of the Employment Agreement or as required by
applicable law. From the Effective Date until the Employment Separation Date, Employee will continue to receive his regular base salary and will remain eligible for all employee benefits to which Employee is currently enlisted. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;Following the Employment Separation Date, the Company shall timely pay to Employee, minus applicable withholdings
and authorized or required deductions: (i)&nbsp;all earned, but unpaid, wages and accrued, but unused, paid time off earned in accordance with Company policy through the Employment Separation Date, to be paid on the next regularly scheduled payroll
date following the Employment Separation Date; (ii)&nbsp;any unpaid expenses or other reimbursements, due to Employee under the Company&#146;s policies, provided that Employee must submit for reimbursement any outstanding business-related expenses
within ten (10)&nbsp;days following the Employment Separation Date, to be paid within 30 days of Company&#146;s receipt of such submission; and (iii)&nbsp;any amounts payable under the Company&#146;s applicable employee benefits plans and programs
in accordance with their terms, including, without limitation, under the Company&#146;s Nonqualified Deferred Compensation Plan, to be paid in accordance with their terms. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;Employee will receive under separate cover information regarding Employee&#146;s rights under the Consolidated
Omnibus Budget Reconciliation Act and, if applicable, any state continuation coverage laws (collectively, &#147;<U>COBRA</U>&#148;). Employee acknowledges that Employee should review the COBRA notice and election forms carefully to understand
Employee&#146;s rights and obligations to make timely elections, provide timely notification and make timely premium payments.&nbsp;&nbsp;&nbsp;&nbsp;For the avoidance of doubt, the parties acknowledge that Section&nbsp;4(f) of the Employment
Agreement regarding Employee&#146;s continuation of benefits following any termination of employment shall survive the execution of this Agreement and continue in full force and effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Consulting Advisory Services</U></B>. During the period
following the Employment Separation Date and ending on February&nbsp;24, 2024 or such prior date as determined by the Company in its sole discretion upon notice to Employee (the &#147;<U>Consulting Advisory Period</U>&#148;), Employee shall make
himself available to provide transition advisory services as reasonably requested by the Company&#146;s new Executive Vice President and General Counsel, the Company&#146;s Chief Human Resources Officer, the Company&#146;s Chief Executive Officer or
the Board of Acadia (the &#147;<U>Consulting Advisory Services</U>&#148;). Employee will provide the Consulting Advisory Services for no more than 30 hours per month. During the Consulting Advisory Period, in consideration of Employee&#146;s
Consulting Advisory Services, continued compliance with the terms and conditions of this Agreement (including, without limitation, Section&nbsp;5) and the occurrence of the Initial Release Effective Date (as defined below), Employee shall be paid
$10,591.88 per month, in accordance with the Company&#146;s standard payroll practices. With respect to services rendered during the Consulting Advisory Period, Employee&#146;s relationship to the Company will only be that of any independent
contractor and, as an independent contractor, Employee agrees to pay in a timely manner all social security and other payroll taxes relating to such compensation. The sole compensation Employee will receive for services during the Consulting
Advisory Period is set forth in this Section&nbsp;2 and Section&nbsp;3 below. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Treatment of Outstanding
Equity Awards</U></B>. Provided that (i)&nbsp;Employee continues to comply with this Agreement (including, without limitation, Section&nbsp;5), (ii) Employee discharges his duties hereunder in a manner reasonably acceptable to the CEO,
(iii)&nbsp;Employee provides the Consulting Advisory Services in accordance with Section&nbsp;2 for the duration of the Consulting Advisory Period, and (iv)&nbsp;the Release becomes effective on the Post-Consultancy Release Effective Date (each, as
defined below) pursuant to its terms, the 2021 PSU Award (as defined below) subject to performance-based vesting will remain outstanding and eligible to vest based on actual achievement of the applicable performance conditions as if no termination
of employment had occurred, subject to the terms and conditions set forth in the applicable award agreement and/or governing documentation; provided, that, in no event shall any portion of the 2021 PSU Award vest in accordance with the foregoing
unless and until the occurrence of the Post-Consultancy Release Effective Date. Employee shall be deemed to have satisfied (i), (ii) and (iii)&nbsp;above unless the Company timely notifies Employee of his material breach of one or more of such
provisions and Employee fails to cure such breach within thirty (30)&nbsp;days of such notice; provided, that, for the avoidance of doubt, any breach of the restrictive covenant obligations set forth in the Employment Agreement or Section&nbsp;5
hereof at any time shall constitute Employee&#146;s failure to satisfy (i)&nbsp;above. If Employee fails to satisfy (i), (ii) or (iii)&nbsp;above, or if the Post-Consultancy Release Effective Date does not occur, Employee shall remain eligible to
vest in only a <FONT STYLE="white-space:nowrap">pro-rata</FONT> share of the 2021 PSU Award based on the Employment Separation Date in accordance with the award agreement. For the avoidance of doubt, all other outstanding equity awards held by
Employee shall be treated in accordance with the terms and conditions of the Acadia Healthcare Company Inc., Incentive Compensation Plan and the applicable award agreement, and, other than with respect to the 2021 PSU Award, Employee&#146;s
separation from employment on the Employment Separation Date shall constitute a &#147;retirement&#148; for purposes of all outstanding performance-vesting restricted stock unit equity awards held by Employee pursuant the terms of the applicable
award agreements. For purposes of this Agreement, the &#147;2021 PSU Award&#148; is the Restricted Stock Unit Award granted to Employee on April&nbsp;23, 2021. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Confidentiality</U></B>. Subject to Section&nbsp;11 below,
Employee agrees that the terms and conditions of this Agreement; the circumstances of Employee&#146;s separation from the Company; all nonpublic, confidential, proprietary and trade secret information that Employee obtained or developed as result of
Employee&#146;s employment with the Company; and any events relating to the Company and/or the Company&#146;s employees that occurred during Employee&#146;s employment with the Company are strictly confidential, except that Employee may disclose the
terms and conditions to Employee&#146;s attorneys, accountants, tax consultants, state and federal tax authorities or as may otherwise be required by law (provided such parties are instructed to comply with this section). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Continuing Obligations; <FONT STYLE="white-space:nowrap">Non-Competition;</FONT> <FONT
STYLE="white-space:nowrap">Non-Solicit</FONT></U></B>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;The parties hereby reaffirm their respective obligations
under the Employment Agreement and agree to comply at all times with their respective post-employment obligations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp; Notwithstanding Section&nbsp;5(a), in further consideration of the compensation and benefits to be paid to
Employee hereunder including, without limitation, as set forth in Sections 2 and 3, Employee acknowledges that during the course of his service with the Company he has and shall become familiar with Acadia&#146;s and its subsidiaries&#146;
(collectively, the &#147;Company Group&#148;) trade secrets and with other confidential information concerning the Company Group and that his services have been and shall be of special, unique and extraordinary value to the Company Group, and,
therefore, Employee agrees that, during the Consulting Advisory Period and for a period thereafter of twenty-four (24)&nbsp;months, he shall not (i)&nbsp;directly or indirectly own any interest in, manage, control, participate in, consult with,
render services for, or in any manner engage in any business that derives at least 25% of its gross revenue from the business of providing behavioral healthcare and/or related services or (ii)&nbsp;directly or indirectly manage, control, participate
in, consult with or render services specifically with respect to any unit, division, segment or subsidiary of any other business that engages in or otherwise competes with (or was organized for the purpose of engaging in or competing with) the
business of providing behavioral healthcare and/or related services (provided that, this clause (ii)&nbsp;shall not be construed to prohibit Employee from directly or indirectly owning any interest in, managing, controlling, participating in,
consulting with, rendering services for, or in any manner engaging in any business activities with or for such business generally and, for the avoidance of doubt, not specifically with respect to such unit, division, segment or subsidiary), in each
case, within any geographical area in which the Company Group engages in such businesses. For purposes of this Agreement, the term &#147;participate in&#148; shall include, without limitation, having any direct or indirect interest in any Person,
whether as a sole proprietor, owner, stockholder, partner, joint venturer, creditor or otherwise, or rendering any direct or indirect service or assistance to any individual, corporation, partnership, joint venture and other business entity (whether
as a director, officer, manager, supervisor, employee, agent, consultant or otherwise). Nothing herein shall prohibit Employee from being a passive owner of not more than 2% of the outstanding stock of any class of a corporation which is publicly
traded, so long as Employee has no active participation in the business of such corporation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding
Section&nbsp;5(a), during the Consulting Advisory Period and for a period of twenty-four (24)&nbsp;months thereafter, Employee shall not directly or indirectly through another person, firm, corporation or other entity (other than on behalf of the
Company Group)&nbsp;(i) induce or attempt to induce any employee or independent contractor of the Company </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Group to leave the employ or services of the Company Group, or in any way interfere with the relationship between the Company Group and any employee or independent contractor thereof,
(ii)&nbsp;hire or seek any business affiliation with any person who was an employee or independent contractor of the Company Group at any time during the twelve (12)&nbsp;months prior to the end of the Consulting Advisory Period or (iii)&nbsp;induce
or attempt to induce any customer, supplier, licensee, licensor or other business relation of the Company Group to cease doing business with the Company Group or interfere with the relationship between any such customer, supplier, licensor or other
business relation and the Company Group. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Release</U></B>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;In consideration of the payments and benefits provided in this Agreement to which Employee would not otherwise be
entitled (including but not limited to the Equity Treatment), the sufficiency of which Employee hereby expressly acknowledge, Employee shall execute, <FONT STYLE="white-space:nowrap">re-execute</FONT> and not revoke a release of claims (the
&#147;Release&#148;) substantially in the form set forth in <U>Exhibit A</U> hereto, in accordance with the following: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;Employee shall have <FONT STYLE="white-space:nowrap">twenty-one</FONT> (21)&nbsp;days from the date of the
Employee&#146;s initial receipt of the Release to consider the terms of the Release, although Employee may sign it at any time sooner. The parties agree that any revisions or modifications to the Release, whether material or immaterial, will not
restart this time period. Employee has seven (7)&nbsp;calendar days after the date on which he initially executes the Release to revoke his consent to the Release. If Employee does not sign the Release or if he revokes his execution of the Release,
this Agreement shall be null and void and the Initial Release Effective Date shall not occur. Provided that Employee timely executes the Release as provided herein and does not revoke his execution of the Release within such seven <FONT
STYLE="white-space:nowrap">(7)-day</FONT> revocation period, this Agreement will become effective on the eighth (8th) calendar day after the date on which Employee signs the Release (the &#147;<U>Initial Release Effective Date</U>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;Employee must <FONT STYLE="white-space:nowrap">re-execute</FONT> the Release within
<FONT STYLE="white-space:nowrap">twenty-one</FONT> (21)&nbsp;days from the expiration of the Consulting Advisory Period. Employee has seven (7)&nbsp;calendar days from the date of such <FONT STYLE="white-space:nowrap">re-execution</FONT> to revoke
his consent to such <FONT STYLE="white-space:nowrap">re-execution.</FONT> If Employee does not <FONT STYLE="white-space:nowrap">re-execute</FONT> the Release or if he timely revokes such <FONT STYLE="white-space:nowrap">re-execution,</FONT> this
Agreement shall remain in full force and effect, except Employee shall not be entitled to the Equity Treatment. Provided that Employee does not revoke his <FONT STYLE="white-space:nowrap">re-execution</FONT> of the Release within such seven <FONT
STYLE="white-space:nowrap">(7)-day</FONT> period, the &#147;<U>Post-Consultancy Release Effective Date</U>&#148; shall occur on the eighth (8th) calendar day after the date on which Employee <FONT STYLE="white-space:nowrap">re-executes</FONT> the
Release. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Company Property</U></B>. Employee acknowledges and agrees that, other than as expressly
approved by the Company and necessary for the provision of the Consulting Advisory Services, Employee has returned, or will return within two (2)&nbsp;days after the Employment Separation Date, all Company property and
<FONT STYLE="white-space:nowrap">non-public,</FONT> confidential, proprietary and/or trade secret information in Employee&#146;s custody, possession or control, in any form whatsoever, including without limitation, equipment, telephones, smart
phones, work-related passwords; PDAs, laptops, credit cards, keys, access cards, identification cards, security devices, network access devices, pagers, confidential or proprietary information, documents, manuals, reports, books, compilations, work
product, <FONT STYLE="white-space:nowrap">e-mail</FONT> messages, recordings, tapes, removable storage </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
devices, hard drives, computers and computer discs, files and data (collectively, &#147;<U>Company Property</U>&#148;), which Employee prepared or obtained during the course of Employee&#146;s
employment with the Company. If Employee discovers any property of the Company or <FONT STYLE="white-space:nowrap">non-public,</FONT> confidential, proprietary and/or trade secret information in Employee&#146;s possession after the Effective Date,
Employee shall promptly return such property to the Company or, at the instruction of the Company, destroy such property or information. Notwithstanding the foregoing, Employee further acknowledges and agrees that Employee will return within two
(2)&nbsp;days after the expiration of the Consulting Advisory Period any Company Property obtained during the Consulting Advisory Period or retained for use during the Consulting Advisory Period with express approval by the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.&nbsp;&nbsp;&nbsp;&nbsp;<B><U>No Admission of Liability; No Prevailing Party</U></B>. The Parties agree that this Agreement is not to be
construed as an admission of any wrongdoing or liability on the part of the Parties under any statute or otherwise, but that on the contrary, any such wrongdoing or liability is expressly denied by the Parties. The Parties agree that neither this
Agreement nor the negotiations in pursuance thereof shall be construed or interpreted to render the Parties a prevailing party for any reason, including but not limited to an award of attorney&#146;s fees, expenses or costs under any statute or
otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Voluntary Execution</U></B>. Employee acknowledges, certifies and agrees that:
(a)&nbsp;Employee has carefully read this Agreement and fully understands all of its terms; (b)&nbsp;Employee had a reasonable amount of time to consider Employee&#146;s decision to execute or <FONT STYLE="white-space:nowrap">re-execute</FONT> (as
applicable) this Agreement; (c)&nbsp;in executing or <FONT STYLE="white-space:nowrap">re-executing</FONT> (as applicable) this Agreement Employee does not rely and has not relied upon any representation or statement made by any of the Company&#146;s
agents, representatives, or attorneys with regard to the subject matter, basis, or effect of the Agreement; and (d)&nbsp;that Employee enters into this Agreement voluntarily, of Employee&#146;s own free will, without any duress and with knowledge of
its meaning and effect in exchange for good and valuable consideration to which Employee would not be entitled in the absence of executing or <FONT STYLE="white-space:nowrap">re-executing</FONT> (as applicable) this Agreement and not revoking the
Release. Employee acknowledges that the Company has advised Employee to consult with an attorney prior to executing or <FONT STYLE="white-space:nowrap">re-executing</FONT> (as applicable) this Agreement and that Employee has had an opportunity to
consult with Employee&#146;s counsel. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Effective Date</U></B>. The first date upon which Employee and the
Company have signed this Agreement and the Company has received Employee&#146;s signature, shall be the &#147;<U>Effective Date</U>&#148;. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Permitted Disclosures</U></B>. Nothing in this Agreement or any other agreement between the Parties or any
other policies of the Company or its affiliates shall prohibit or restrict Employee or Employee&#146;s attorneys from: (a)&nbsp;making any disclosure of relevant and necessary information or documents in any action, investigation, or proceeding
relating to this Agreement, or as required by law or legal process, including with respect to possible violations of law; (b)&nbsp;participating, cooperating, or testifying in any action, investigation, or proceeding with, or providing information
to, any governmental agency or legislative body, any self-regulatory organization, and/or pursuant to the Sarbanes-Oxley Act; or (c)&nbsp;accepting any U.S. Securities and Exchange Commission awards. In addition, nothing in this Agreement or any
other agreement between the Parties or any other policies of the Company or its affiliates prohibits or restricts </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Employee from initiating communications with, or responding to any inquiry from, any regulatory or supervisory authority regarding any good faith concerns about possible violations of law or
regulation. Pursuant to 18 U.S.C. &#167; 1833(b), Employee will not be held criminally or civilly liable under any Federal or state trade secret law for the disclosure of a trade secret of the Company or its affiliates that (i)&nbsp;is made
(x)&nbsp;in confidence to a Federal, state, or local government official, either directly or indirectly, or to Employee&#146;s attorney and (y)&nbsp;solely for the purpose of reporting or investigating a suspected violation of law; or (ii)&nbsp;is
made in a complaint or other document that is filed under seal in a lawsuit or other proceeding. If Employee files a lawsuit for retaliation by the Company for reporting a suspected violation of law, Employee may disclose the trade secret to
Employee&#146;s attorney and use the trade secret information in the court proceeding, if Employee files any document containing the trade secret under seal, and does not disclose the trade secret, except pursuant to court order. Nothing in this
Agreement or any other agreement between the Parties or any other policies of the Company or its affiliates is intended to conflict with 18 U.S.C. &#167; 1833(b) or create liability for disclosures of trade secrets that are expressly allowed by such
section. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12.&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Successors and Assigns; Third-Party Beneficiaries</U></B>. The Parties agree that this
Agreement shall inure to the benefit of and be enforceable by the personal or legal representatives, heirs, executors, and administrators of Employee. This Agreement may not be assigned by Employee. The Company may freely assign all rights and
obligations of this Agreement to any affiliate or successor (including to a purchaser of assets). The Released Parties are expressly intended to be third-party beneficiaries of this Agreement and it may be enforced by each of them. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13.&nbsp;&nbsp;&nbsp;&nbsp;<B><U>No Oral Modifications</U></B>. This Agreement shall not be modified except in writing signed by Employee and
an authorized representative of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14.&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Severability</U></B>. If any terms of the above provisions
of this Agreement are found null, void or inoperative, for any reason, the remaining provisions will remain in full force and effect. The language of all parts of this Agreement shall in all cases be construed as a whole, according to its fair
meaning, and not strictly for or against either of the Parties. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15.&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Counterparts</U></B>. This Agreement may
be executed in counterparts, each of which will be deemed an original but all of which together will constitute one and the same instrument. An originally executed version of this Agreement that is scanned as an image file (e.g., Adobe PDF, TIF,
etc.) and then delivered by one Party to the other Party via electronic mail as evidence of signature, shall, for all purposes hereof, be deemed an original signature. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">16.&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Governing Law; Jurisdiction; Waiver of Jury Trial</U></B>. The Parties agree that this Agreement and the
rights and obligations hereunder shall be governed by, and construed in accordance with, the laws of the State of Delaware regardless of any principles of conflicts of laws or choice of laws of any jurisdiction. The Parties agree that any action
between Employee and the Company shall be resolved exclusively in a federal or state court in Tennessee, and the Company and Employee hereby consent to such jurisdiction and waive any objection to the jurisdiction of any such court. As a
specifically bargained for inducement for each of the Parties to enter into this Agreement, Employee and the Company (after having the opportunity to consult with counsel) hereby waive trial by jury as to any and all litigation arising out of and/or
relating to this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">17.&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Entire Agreement</U></B>. This Agreement and the Employment
Agreement constitute the complete and entire agreement and understanding of the Parties, and supersede in their entirety any and all prior understandings, negotiations, commitments, obligations and/or agreements, whether written or oral, between the
Parties. The Parties represent that, in executing or <FONT STYLE="white-space:nowrap">re-executing</FONT> (as applicable) this Agreement, each Party has not relied upon any representation or statement made by the other Party, other than those set
forth in this Agreement, with regard to the subject matter, basis or effect of this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the Parties have duly executed or
<FONT STYLE="white-space:nowrap">re-executed,</FONT> as applicable, this Agreement as of the below-indicated date(s). </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="47%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>EMPLOYEE</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Christopher L. Howard</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">July&nbsp;5, 2023</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Christopher L. Howard</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Date</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>ACADIA MANAGEMENT COMPANY, LLC</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Christopher H. Hunter</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">July&nbsp;5, 2023</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">(Signature)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Date</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Name: Christopher H. Hunter</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Title: President</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>ACADIA HEALTHCARE COMPANY, INC.</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Christopher H. Hunter</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">July&nbsp;5, 2023</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">(Signature)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Date</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Name: Christopher H. Hunter</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Title: Chief Executive Officer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B></B><B><I>Execution Version</I></B><B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>EXHIBIT A </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>GENERAL RELEASE </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">I, Chris Howard, in consideration of and subject to the performance by Acadia Management Company, LLC, a Delaware corporation (together with
its subsidiaries and affiliates, the &#147;<U>Company</U>&#148;), of its obligations under the Separation and Transition Agreement, dated as of July&nbsp;3, 2023 (the &#147;<U>Agreement</U>&#148;), do hereby release and forever discharge as of the
date of my execution or <FONT STYLE="white-space:nowrap">re-execution,</FONT> as applicable, of this General Release, the Company and its affiliates and all present and former directors, officers, agents, representatives, employees, successors and
assigns of the Company and its affiliates and the Company&#146;s direct and indirect owners (collectively, the &#147;<U>Released Parties</U>&#148;) to the extent provided below. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">I understand that certain payments or benefits to which I am entitled under Section&nbsp;3 of the Agreement represent, in part, consideration
for signing this General Release and are not salary, wages or benefits to which I was already entitled. I understand and agree that I will not receive certain payments and benefits specified in Section&nbsp;3 of the Agreement unless I execute and <FONT
STYLE="white-space:nowrap">re-execute</FONT> this General Release and do not revoke such execution and <FONT STYLE="white-space:nowrap">re-execution</FONT> of this General Release within the time period permitted hereafter and do not breach this
General Release or Section&nbsp;6 of the Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as provided in this paragraph below and except for the provisions of the
Amended and Restated Employment Agreement dated April&nbsp;7, 2014 (the &#147;Employment Agreement&#148;) and the Agreement which expressly survive the termination of my employment or service with the Company, I knowingly and voluntarily (for
myself, my heirs, executors, administrators and assigns) release and forever discharge the Company and the other Released Parties from any and all claims, suits, controversies, actions, causes of action, cross-claims, counter-claims, demands, debts,
compensatory damages, liquidated damages, punitive or exemplary damages, other damages, claims for costs and attorneys&#146; fees, or liabilities of any nature whatsoever in law and in equity, both past and present (through the date I execute or <FONT
STYLE="white-space:nowrap">re-execute,</FONT> as applicable, this General Release) and whether known or unknown, suspected, or claimed against the Company or any of the Released Parties which I, my spouse, or any of my heirs, executors,
administrators or assigns, may have, which arise out of or are connected with my employment with, serviced rendered to, or my separation or termination from, the Company (including, but not limited to, any allegation, claim or violation, arising
under: Title VII of the Civil Rights Act of 1964, as amended; the Civil Rights Act of 1991; the Age Discrimination in Employment Act of 1967, as amended (including the Older Workers Benefit Protection Act); the Equal Pay Act of 1963, as amended; the
Americans with Disabilities Act of 1990; the Family and Medical Leave Act of 1993; the Worker Adjustment Retraining and Notification Act; the Employee Retirement Income Security Act of 1974; any applicable Executive Orders; the Fair Labor Standards
Act; or their state or local counterparts; or under any other federal, state or local civil or human rights law, or under any other local, state, or federal law, regulation or ordinance; or under any public policy, contract or tort, or under common
law; or arising under any policies, practices or procedures of the Company; or any claim for wrongful discharge, breach of contract, infliction of emotional distress, defamation; or any claim for costs, fees, or other expenses, including
attorneys&#146; fees incurred in these matters) (all of the foregoing collectively referred to herein as the &#147;<U>Claims</U>&#148;); provided that, this General Release shall not apply to or affect or impair (i)&nbsp;Claims for vested benefits
pursuant to any Company employee </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
benefit plan in which I was a participant prior to the termination of my employment with the Company; (ii)&nbsp;any Claims for unemployment insurance benefits or workers&#146; compensation
benefits applicable to the period through the termination of my employment with the Company; or (iii)&nbsp;any Claims that may arise for my indemnification under any directors and officers or similar insurance, or under the certificate of
incorporation, bylaws, limited liability company agreement, certificate of formation and/or other applicable governing documents of the Company, its subsidiaries and/or affiliates. Additionally, notwithstanding Section&nbsp;5(a) of the Agreement, I
agree and acknowledge that the duration of the <FONT STYLE="white-space:nowrap">&#147;Non-Disparagement</FONT> Period&#148; set forth in Section&nbsp;7(c) of the Employment Agreement is hereby amended to last during the Employment Period (as defined
in the Employment Agreement) and at all times thereafter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">I represent that I have made no assignment or transfer of any right, claim,
demand, cause of action, or other matter covered by paragraph 2 above. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">I agree that this General Release does not waive or release any
rights or claims that I may have under the Age Discrimination in Employment Act of 1967 which arise after the date I execute or <FONT STYLE="white-space:nowrap">re-execute,</FONT> as applicable, this General Release). I acknowledge and agree that my
separation from employment and service with the Company is in compliance with the terms of the Employment Agreement, the Agreement and company policy and shall not serve as the basis for any Claim (including, without limitation, any claim under the
Age Discrimination in Employment Act of 1967). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">I agree that I am waiving all rights to sue or obtain equitable, remedial or punitive
relief from any or all Released Parties of any kind whatsoever, including, without limitation, reinstatement, back pay, front pay, attorneys&#146; fees and any form of injunctive relief. Notwithstanding the above, I further acknowledge that I am not
waiving and am not being required to waive any right that cannot be waived under applicable law, including the right to file an administrative charge or participate in an administrative investigation or proceeding; provided, however, that I disclaim
and waive any right to share or participate in any monetary award resulting from the prosecution of such charge or investigation or proceeding, excepting any benefit or remedy to which I am entitled pursuant to Section&nbsp;922 of the Dodd-Frank
Wall Street Reform and Consumer Protection Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In signing this General Release, I acknowledge and intend that it shall be effective as a
bar to each and every one of the Claims hereinabove mentioned. I expressly consent that this General Release shall be given full force and effect according to each and all of its express terms and provisions, including those relating to unknown and
unsuspected Claims (notwithstanding any state statute that expressly limits the effectiveness of a general release of unknown, unsuspected and unanticipated Claims), if any, as well as those relating to any other Claims hereinabove mentioned. I
acknowledge and agree that this waiver is an essential and material term of this General Release and that without such waiver the Company would not have agreed to the terms of the Agreement. I further agree that in the event I should bring a Claim
seeking damages against the Company, or in the event I should seek to recover against the Company in any Claim brought by a governmental agency on my behalf, this General Release shall serve as a complete defense to such Claims to the maximum extent
permitted by applicable law. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Nothing in the Employment Agreement, the Agreement or this General Release shall prohibit or
restrict me or my attorneys from: (i)&nbsp;making any disclosure of relevant and necessary information or documents in any action, investigation, or proceeding relating to this General Release, or as required by law or legal process, including with
respect to possible violations of law; (ii)&nbsp;participating, cooperating, or testifying in any action, investigation, or proceeding with, or providing information to, any governmental agency or legislative body, any self-regulatory organization,
and/or pursuant to the Sarbanes-Oxley Act; (iii)&nbsp;accepting any U.S. Securities and Exchange Commission awards; or (iv)&nbsp;initiating communications with, or responding to any inquiry from, any regulatory or supervisory authority regarding any
good faith concerns about possible violations of law or regulation. Pursuant to 18 U.S.C. &#167; 1833(b), I will not be held criminally or civilly liable under any Federal or state trade secret law for the disclosure of a trade secret of the Company
that (A)&nbsp;is made (x)&nbsp;in confidence to a Federal, state, or local government official, either directly or indirectly, or to my attorney and (y)&nbsp;solely for the purpose of reporting or investigating a suspected violation of law; or
(B)&nbsp;is made in a complaint or other document that is filed under seal in a lawsuit or other proceeding. If I file a lawsuit for retaliation by the Company for reporting a suspected violation of law, I may disclose the trade secret to my
attorney and use the trade secret information in the court proceeding, if I file any document containing the trade secret under seal, and do not disclose the trade secret, except pursuant to court order. Nothing in this General Release is intended
to conflict with 18 U.S.C. &#167; 1833(b) or create liability for disclosures of trade secrets that are expressly allowed by such section. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">I represent that I am not aware of any pending charge or complaint of the type described in paragraph 2 above as of the execution or <FONT
STYLE="white-space:nowrap">re-execution,</FONT> as applicable, of this General Release. I represent that I am not aware of any claim by me other than the claims that are released by this General Release. I acknowledge that I may hereafter discover
claims or facts in addition to or different than those which I now know or believe to exist with respect to the subject matter of the release set forth in paragraph 2 above and which, if known or suspected at the time of executing or <FONT
STYLE="white-space:nowrap">re-executing,</FONT> as applicable, this General Release, may have materially affected this General Release and my decision to enter into it. Nevertheless, I hereby waive any right, claim or cause of action that might
arise as a result of such different or additional claims or facts. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">I agree that I will forfeit all amounts payable by the Company
pursuant to Section&nbsp;3 the Agreement if I challenge the validity of this General Release. I also agree that if I violate this General Release by suing the Company or the other Released Parties, I will pay all costs and expenses of defending
against the suit incurred by the Released Parties, including reasonable attorneys&#146; fees, and upon the Company&#146;s request return all payments theretofore received by me pursuant to Section&nbsp;3 of the Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Whenever possible, each provision of this General Release will be interpreted in, such manner as to be effective and valid under applicable
law, but if any provision of this General Release is held to be invalid, illegal or unenforceable in any respect under any applicable law or rule in any jurisdiction, such invalidity, illegality or unenforceability will not affect any other
provision or any other jurisdiction, but this General Release will be reformed, construed and enforced in such jurisdiction as if such invalid, illegal or unenforceable provision had never been contained herein. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding anything in this General Release to the contrary, this General Release shall
not relinquish, diminish, or in any way affect any rights or claims arising out of any breach by the Company or any Released Party of the Employment Agreement or Agreement after the date hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Released Parties are intended to be third-party beneficiaries of this General Release, and this General Release may be enforced by each of
them in accordance with the terms hereof in respect of the rights granted to such Released Parties hereunder. The personal or legal representatives, heirs, executors, and administrators of Employee are intended to be third-party beneficiaries of
this General Release, and this General Release may be enforced by each of them in accordance with the terms hereof in respect of the rights granted to them hereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;16 of the Agreement is incorporated herein and all references to the Agreement shall be to this General Release. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BY SIGNING THIS GENERAL RELEASE, I REPRESENT AND AGREE THAT: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I
HAVE READ IT CAREFULLY; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I UNDERSTAND ALL OF ITS TERMS AND KNOW THAT I AM GIVING UP IMPORTANT RIGHTS, INCLUDING BUT NOT LIMITED TO, RIGHTS UNDER THE AGE
DISCRIMINATION IN EMPLOYMENT ACT OF 1967, AS AMENDED, TITLE VII OF THE CIVIL RIGHTS ACT OF 1964, AS AMENDED; THE EQUAL PAY ACT OF 1963, THE AMERICANS WITH DISABILITIES ACT OF 1990; AND THE EMPLOYEE RETIREMENT INCOME SECURITY ACT OF 1974, AS AMENDED;
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I VOLUNTARILY CONSENT TO EVERYTHING IN IT IN EXCHANGE FOR GOOD AND VALUABLE CONSIDERATION TO WHICH I WOULD NOT BE ENTITLED IN THE ABSENCE OF EXECUTING, <FONT
STYLE="white-space:nowrap">RE-EXECUTING</FONT> AND NOT REVOKING THIS GENERAL RELEASE; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I HAVE BEEN ADVISED TO CONSULT WITH AN ATTORNEY BEFORE EXECUTING IT
AND I HAVE DONE SO OR, AFTER CAREFUL READING AND CONSIDERATION, I HAVE CHOSEN NOT TO DO SO OF MY OWN VOLITION; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I HAVE HAD AT LEAST 21 DAYS FROM THE DATE
OF MY FIRST RECEIPT OF THIS GENERAL RELEASE TO CONSIDER IT (ALTHOUGH I MAY SIGN IT SOONER) AND ANY CHANGES (EITHER MATERIAL OR IMMATERIAL) MADE TO THIS GENERAL RELEASE WILL NOT RESTART THE REQUIRED <FONT STYLE="white-space:nowrap">21-DAY</FONT>
PERIOD; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I UNDERSTAND THAT I HAVE SEVEN DAYS AFTER THE INITIAL EXECUTION OF THIS GENERAL RELEASE TO REVOKE IT AND THAT THIS GENERAL RELEASE SHALL NOT
BECOME EFFECTIVE OR ENFORCEABLE UNTIL THE REVOCATION PERIOD HAS EXPIRED; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I UNDERSTAND THAT IF I DO NOT SIGN THIS GENERAL RELEASE OR IF I REVOKE MY INITIAL EXECUTION OF THIS GENERAL
RELEASE, THE GENERAL RELEASE WILL BE VOID AND OF NO FORCE AND EFFECT AND NEITHER MYSELF NOR THE COMPANY WILL HAVE ANY RIGHTS OR OBLIGATIONS UNDER THE AGREEMENT OR THIS GENERAL RELEASE; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I UNDERSTAND THAT I HAVE SEVEN DAYS AFTER MY <FONT STYLE="white-space:nowrap">RE-EXECUTION</FONT> OF THIS GENERAL RELEASE TO REVOKE SUCH <FONT
STYLE="white-space:nowrap">RE-EXECUTION</FONT> AND THAT THIS THAT THE <FONT STYLE="white-space:nowrap">RE-EXECUTION</FONT> OF THIS RELEASE WILL NOT BECOME EFFECTIVE OR ENFORCEABLE UNTIL SUCH REVOCATION PERIOD HAS EXPIRED; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">THE <FONT STYLE="white-space:nowrap">RE-EXECUTION</FONT> OF THIS GENERAL RELEASE WILL ADVANCE THE RELEASE IN PARAGRAPH 2 ABOVE TO THE SECOND EXECUTION DATE;
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IF I DO NOT <FONT STYLE="white-space:nowrap">RE-EXECUTE</FONT> THIS GENERAL RELEASE OR IF I REVOKE MY
<FONT STYLE="white-space:nowrap">RE-EXECUTION</FONT> AS PROVIDED ABOVE, THIS RELEASE SHALL REMAIN IN FULL FORCE AND EFFECT, INCLUDING BUT NOT LIMITED TO THE RELEASE IN PARAGRAPH 2, THROUGH THE FIRST EXECUTION DATE; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I HAVE EXECUTED OR <FONT STYLE="white-space:nowrap">RE-EXECUTED,</FONT> AS APPLICABLE, THIS GENERAL RELEASE KNOWINGLY AND VOLUNTARILY AND WITH THE ADVICE OF
ANY COUNSEL RETAINED TO ADVISE ME WITH RESPECT TO IT; AND </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I AGREE THAT THE PROVISIONS OF THIS GENERAL RELEASE MAY NOT BE AMENDED, WAIVED, CHANGED OR
MODIFIED EXCEPT BY AN INSTRUMENT IN WRITING SIGNED BY AN AUTHORIZED REPRESENTATIVE OF THE COMPANY AND BY ME. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">AGREED AND ACKNOWLEDGED</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>EMPLOYEE:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; ">
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:1pt;border-bottom:1px solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Christopher L. Howard</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:__________</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>NOT TO BE <FONT STYLE="white-space:nowrap">RE-EXECUTED</FONT> PRIOR TO THE EXPIRATION OF THE CONSULTING ADVISORY PERIOD</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="white-space:nowrap">RE-EXECUTED</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>EMPLOYEE:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; ">
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:1pt;border-bottom:1px solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Christopher L. Howard</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:__________</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>d434500dex102.htm
<DESCRIPTION>EX-10.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.2 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B></B><B><I>EXECUTION VERSION</I></B><B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>TRANSITION AGREEMENT </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Transition Agreement (&#147;<U>Agreement</U>&#148;) by and between Acadia Management Company, LLC (the &#147;<U>Company</U>&#148;) and
David Duckworth (&#147;<U>Executive</U>&#148;), and for the purposes of <U>Section</U><U></U><U>&nbsp;4</U> only, Acadia Healthcare Company, Inc. (&#147;<U>Acadia</U>&#148;), is entered into and effective as of July&nbsp;5, 2023. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>WHEREAS</B>, the Company and Executive are parties to an Employment Agreement, dated April&nbsp;7, 2014, (the &#147;<U>Employment
Agreement</U>&#148;); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>WHEREAS</B>,<B> </B>Executive is resigning as Chief Financial Officer (&#147;<U>CFO</U>&#148;) of the Company
effective on the CFO Resignation Date (as defined below), after which, Executive will continue to be employed by the Company as an advisor until the Employment Separation Date (as defined below), after which, Executive shall provide Consulting
Advisory Services (as defined below) to the Company as provided under this Agreement; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>WHEREAS</B>, Executive and the Company
desire to enter into this Agreement to memorialize Executive&#146;s and the Company&#146;s rights and obligations with respect to Executive&#146;s resignation from his position as CFO, separation from employment, and provision of the Consulting
Advisory Services. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>NOW, THEREFORE</B>, in consideration of the premises and mutual covenants and conditions set forth hereinafter, and
for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, Company and Executive, intending to be legally bound, agree as follows: </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>1.&nbsp;&nbsp;&nbsp;&nbsp;<U>CFO Resignation; Cessation of Employment Relationship.</U></B> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;Executive shall continue to serve as CFO of the Company until July&nbsp;9, 2023 (the &#147;<U>CFO
Resignation Date</U>&#148;), upon which date Executive shall resign, and shall be automatically deemed to have resigned without the requirement of any further action, from his position as CFO of the Company. Following the CFO Resignation Date, the
Company shall continue to employ Executive as an advisor until July&nbsp;31, 2023 or such earlier date as determined by Acadia&#146;s Board of Directors (the &#147;<U>Board</U>&#148;) in its sole discretion (the &#147;<U>Employment Separation
Date</U>&#148;), upon which date Executive shall promptly resign, and shall be automatically deemed to have resigned without the requirement of any further action, from such advisor position and any other positions at the Company and its affiliates
(whether as an officer, director, member of any board of directors and/or fiduciary or otherwise). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;From the date of this Agreement until the CFO Resignation Date (the &#147;<U>Continued CFO Service
Period</U>&#148;), Executive shall (i)&nbsp;devote his best efforts and substantially all of his business time and attention to the business affairs of the Company and Acadia (except for periods of scheduled personal time off, illness or other
incapacity); (ii) continue to perform his full-time duties and responsibilities as the Company&#146;s CFO to the best of his abilities in a diligent, trustworthy, businesslike and efficient manner; and (iii)&nbsp;comply with the Employment Agreement
and all Company written or established policies, rules and regulations governing the conduct of its employees, now in effect, or as subsequently adopted or amended. The Executive agrees that the Company may, in its sole discretion, <FONT
STYLE="white-space:nowrap">re-assign</FONT> all or any portion of the Executive&#146;s duties and responsibilities and the Executive acknowledges and agrees that any such action shall not constitute &#147;Good Reason&#148; (or similar term) under
any arrangement or agreement or otherwise be a breach of the Employment Agreement or other agreement </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;During the period following the CFO Resignation
Date and ending on the Employment Separation Date (the &#147;<U>Employee Advisory Service Period</U>&#148;), Executive shall continue to be employed by the Company and shall provide transition advisory services as reasonably requested by the
Company&#146;s new CFO, Chief Executive Officer or Board of Acadia and be in conformance and comply with the Employment Agreement and all Company written or established policies, rules and regulations governing the conduct of its employees, now in
effect, or as subsequently adopted or amended. For the avoidance of doubt, the commencement of the Employee Advisory Service Period shall not constitute &#147;Good Reason&#148; (or similar term) under any arrangement or agreement or otherwise be a
breach of the Employment Agreement or other agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;During the Continued CFO Service Period
and the Employee Advisory Service Period, subject to Executive&#146;s continued compliance with the terms and conditions of this Agreement and timely execution and <FONT STYLE="white-space:nowrap">non-revocation</FONT> of the Release (as defined
below) in accordance with this Agreement, Executive shall continue to (i)&nbsp;receive the Base Salary in accordance with Section&nbsp;3(a) of the Employment Agreement and (ii)&nbsp;be entitled to benefits pursuant to Section&nbsp;3(e) of the
Employment Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;The Employment Separation Date will be the termination date of
Executive&#146;s employment for purposes of active participation in and coverage under all benefit plans and programs sponsored by or through the Company, except as otherwise required by law or the terms of such plans or programs. For the avoidance
of doubt, compensation received by Executive during the Continued CFO Service Period and the Employee Advisory Service Period shall continue to be subject to all applicable withholding taxes. The &#147;qualifying event&#148; pursuant to
Executive&#146;s rights under the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (&#147;<U>COBRA</U>&#148;), if any, will occur on the Employment Separation Date. Executive will be notified in writing of the benefits that may be
continued under COBRA and of the terms, conditions and limitation of such continuance in accordance with COBRA, which terms conditions and limitations will be consistent with Section&nbsp;4(f) of the Employment Agreement. For the avoidance of doubt,
the parties acknowledge that Section&nbsp;4(f) of the Employment Agreement regarding Executive&#146;s continuation of benefits following any termination of employment shall survive the execution of this Agreement and continue in full force and
effect. For the avoidance of doubt, the Company will not provide any payments for any costs associated with COBRA benefits. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.</B>&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Final Wages; No Other Payments</U></B>. On the next regularly scheduled pay date
following the Employment Separation Date (or such earlier date as required by applicable law), Executive will receive from the Company (i)&nbsp;all earned but unpaid base salary and accrued, but unused, vacation time earned in accordance with
applicable law and Company policy through the Employment Separation Date; (ii)&nbsp;any expenses or other reimbursement for all business expenses incurred in accordance with Company policies and not yet reimbursed by the Company; (iii)&nbsp;any
amounts payable under the Company&#146;s applicable employee benefits plans and programs in accordance with their terms. The </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
Company shall timely pay to Executive any amounts payable under the Company&#146;s Nonqualified Deferred Compensation Plan in accordance with the terms of thereof. Executive acknowledges that,
except as expressly provided in this Agreement or as otherwise required by applicable law, Executive will not receive any additional compensation, severance or other benefits as an employee of any kind following the Employment Separation Date or the
expiration of the Consulting Advisory Period (as defined below). Executive acknowledges and agrees that this Agreement and any compensation, severance or other benefits provided herein supersede any and all prior agreements or understandings between
Executive and the Company and its affiliates with respect to any compensation, severance or other benefits, whether written or oral, including but not limited to, those provided under the Employment Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>3.</B>&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Consulting Advisory Services</U></B>.<B> </B>During the period following the Employment
Separation Date and ending on the date on which Acadia files with U.S. Securities and Exchange Commission its annual report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> with respect to the fiscal year ending December&nbsp;31, 2023 or such
prior date as determined by the Company in its sole discretion upon notice to Executive (the &#147;<U>Consulting Advisory Period</U>&#148;), Executive shall make himself available to provide transition advisory services as reasonably requested by
the Company&#146;s new CFO, Chief Executive Officer or Board of Acadia (the &#147;<U>Consulting Advisory Services</U>&#148;). During the Consulting Advisory Period, in consideration of Executive&#146;s Consulting Advisory Services, continued
compliance with the terms and conditions of this Agreement (including, without limitation, <U>Section</U><U></U><U>&nbsp;6</U>), the discharge of Executive&#146;s duties as CFO in a manner reasonably acceptable to the CEO, and the timely execution
of the Release in accordance with this Agreement, Executive shall be paid $11,574.89 per month, in accordance with the Company&#146;s standard payroll practices. The Company shall be precluded from claiming Executive has failed to satisfactorily
perform the Consulting Advisory Services under this Section&nbsp;3 unless Executive has materially breached the requirements of this Section&nbsp;3 and has failed to cure to the Company&#146;s reasonable satisfaction within thirty (30)&nbsp;days
after written notice thereof to Executive; provided, that, for the avoidance of doubt, any breach of the restrictive covenant obligations set forth in the Employment Agreement or Section&nbsp;6(b) hereof at any time shall constitute Executive&#146;s
failure to satisfactorily perform the Consulting Advisory Services. With respect to services rendered during the Consulting Advisory Period, Executive&#146;s relationship to the Company will only be that of any independent contractor and, as an
independent contractor, Executive agrees to pay in a timely manner all social security and other payroll taxes relating to such compensation. The sole compensation Executive will receive for services during Consulting Advisory Period is set forth in
this <U>Section</U><U></U><U>&nbsp;3</U> and <U>Section</U><U></U><U>&nbsp;4</U>, below. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>4.</B>&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Treatment of Outstanding Equity Awards</U></B>. Subject to Executive&#146;s continued
compliance with the terms and conditions of this Agreement (including, without limitation, <U>Section</U><U></U><U>&nbsp;6</U>), the discharge of Executive&#146;s duties hereunder in a manner reasonably acceptable to the CEO, provision of the
Consulting Advisory Services in accordance with <U>Section</U><U></U><U>&nbsp;3</U> for the duration of the Consulting Advisory Period, and the timely execution and <FONT STYLE="white-space:nowrap">re-execution</FONT> of the Release in accordance
with this Agreement, the 2021 PSU Award subject to performance-based vesting will remain outstanding and eligible to vest based on actual achievement of the applicable performance conditions as if </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
no termination of employment had occurred, subject to the terms and conditions set forth in the applicable award agreement and/or governing documentation; provided, that, in no event shall any
portion of the 2021 Award vest in accordance with the foregoing unless and until the occurrence of the Post-Consultancy Release Effective Date (as defined below). The Company shall be precluded from claiming Executive has failed to satisfactorily
perform Consulting Advisory Services under this Section unless Executive has materially breached the requirements of Section&nbsp;3 of this Agreement (and has failed to cure to the Company&#146;s reasonable satisfaction within thirty (30)&nbsp;days
after written notice thereof to Executive; provided, that, for the avoidance of doubt, any breach of the restrictive covenant obligations set forth in the Employment Agreement or Section&nbsp;6(b) hereof at any time shall constitute Executive&#146;s
failure to satisfactorily perform the Consulting Advisory Services. For the avoidance of doubt, all other equity-related awards that have not fully vested as of the Employment Separation Date will be forfeited and cancelled without consideration
effective as of the Employment Separation Date in accordance with their terms. For purposes of this Agreement, the &#147;2021 PSU Award&#148; is the Restricted Stock Unit Award granted to Executive on April&nbsp;23, 2021. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.</B>&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Release of Claims</U></B>. In consideration of the payments and benefits provided in
this Agreement to which Executive would not otherwise be entitled (including but not limited to the Equity Treatment), the sufficiency of which Executive hereby expressly acknowledge, Executive shall execute,
<FONT STYLE="white-space:nowrap">re-execute</FONT> and not revoke a release of claims (the &#147;<U>Release</U>&#148;) substantially in the form set forth in Exhibit A of the Employment Agreement, in accordance with the following: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;Executive shall have <FONT STYLE="white-space:nowrap">twenty-one</FONT> (21)&nbsp;days from the date
of the Executive&#146;s initial receipt of the Release to consider the terms of the Release, although Executive may sign it at any time sooner. The parties agree that any revisions or modifications to the Release, whether material or immaterial,
will not restart this time period. Executive has seven (7)&nbsp;calendar days after the date on which he initially executes the Release to revoke his consent to the Release. If Executive does not sign the Release or if he revokes his execution of
the Release, this Agreement shall be null and void and the &#147;Release Effective Date&#148; (as defined below) shall not occur. Provided that Executive timely executes the Release as provided herein and does not revoke his execution of the Release
within such seven <FONT STYLE="white-space:nowrap">(7)-day</FONT> revocation period, this Agreement will become effective on the eighth (8th) calendar day after the date on which Executive signs the Release (the &#147;<U>Release Effective
Date</U>&#148;). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;Executive must <FONT STYLE="white-space:nowrap">re-execute</FONT> the Release
within <FONT STYLE="white-space:nowrap">twenty-one</FONT> (21)&nbsp;days from the expiration of the Consulting Advisory Period. Executive has seven (7)&nbsp;calendar days from the date of such <FONT STYLE="white-space:nowrap">re-execution</FONT> to
revoke his consent to such <FONT STYLE="white-space:nowrap">re-execution.</FONT> If Executive does not <FONT STYLE="white-space:nowrap">re-execute</FONT> the Release or if he timely revokes such <FONT STYLE="white-space:nowrap">re-execution,</FONT>
this Agreement shall remain in full force and effect, except Executive shall not be entitled to the Equity Treatment. Provided that Executive does not revoke his <FONT STYLE="white-space:nowrap">re-execution</FONT> of the Release within such seven <FONT
STYLE="white-space:nowrap">(7)-day</FONT> period, the &#147;<U>Post-Consultancy Release Effective Date</U>&#148; shall occur on the eighth (8th) calendar day after the date on which Executive <FONT STYLE="white-space:nowrap">re-executes</FONT> the
Release. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6.&nbsp;&nbsp;&nbsp;&nbsp;<U>No Integration; <FONT
STYLE="white-space:nowrap">Non-Competition</FONT></U>.</B> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;In the interest of clarity, any
agreement relating to confidentiality, noncompetition, nondisparagement, nonsolicitation or assignment of inventions shall not be superseded by this Agreement and Executive acknowledges and agrees that any such agreement shall remain in full force
and effect. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding <U>Section</U><U></U><U>&nbsp;6(a)</U>, in further consideration of
the compensation and benefits to be paid to Executive hereunder including, without limitation as set forth in <U>Sections 3</U> and <U>4</U>, Executive acknowledges that during the course of his service with the Company he has and shall become
familiar with Acadia&#146;s and its Subsidiaries&#146; (collectively, the &#147;<U>Company Group</U>&#148;) trade secrets and with other confidential information concerning the Company Group and that his services have been and shall be of special,
unique and extraordinary value to the Company Group, and, therefore, Executive agrees that, during the Consulting Advisory Period and for a period thereafter of twelve (12)&nbsp;months, he shall not (i)&nbsp;directly or indirectly own any interest
in, manage, control, participate in, consult with, render services for, or in any manner engage in any business that derives at least 25% of its gross revenue from the business of providing behavioral healthcare and/or related services or
(ii)&nbsp;directly or indirectly manage, control, participate in, consult with or render services specifically with respect to any unit, division, segment or subsidiary of any other business that engages in or otherwise competes with (or was
organized for the purpose of engaging in or competing with) the business of providing behavioral healthcare and/or related services (provided that, this clause (ii)&nbsp;shall not be construed to prohibit Executive from directly or indirectly owning
any interest in, managing, controlling, participating in, consulting with, rendering services for, or in any manner engaging in any business activities with or for such business generally and, for the avoidance of doubt, not specifically with
respect to such unit, division, segment or subsidiary), in each case, within any geographical area in which the Company Group engages in such businesses. For purposes of this Agreement, the term &#147;participate in&#148; shall include, without
limitation, having any direct or indirect interest in any Person, whether as a sole proprietor, owner, stockholder, partner, joint venturer, creditor or otherwise, or rendering any direct or indirect service or assistance to any individual,
corporation, partnership, joint venture and other business entity (whether as a director, officer, manager, supervisor, employee, agent, consultant or otherwise). Nothing herein shall prohibit Executive from being a passive owner of not more than 2%
of the outstanding stock of any class of a corporation which is publicly traded, so long as Executive has no active participation in the business of such corporation. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>7.</B>&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Return of Company Property</U></B>. Executive acknowledges that he has returned all
property of the Company, Acadia and their affiliates (including, but not limited to, phones, computers, keys, electronic devices, office equipment, records, identification cards, files, reports, computer disks, rolodexes, electronic passwords and
documents containing the Company&#146;s, Acadia&#146;s or their affiliates&#146; confidential or business information, whether in hard copy or electronic format) to the Company as of the Employment Separation Date (other than as expressly approved
by the Company and necessary for the provision of the Consulting Advisory Services). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>8.</B>&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Amendment</U></B>. This Agreement
shall not be amended, modified or supplemented except by a written instrument signed by the parties hereto. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>9.</B>&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Notices</U></B>. Any notice provided in this Agreement shall be in writing and sent via
email, overnight delivery service or U.S. mail, return receipt requested, to the recipient at the address indicated on the signature page to this Agreement. Notice of a change in address of one of the parties shall be given in writing to the other
party as provided above. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>10.</B>&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Entire Agreement</U></B>. Except as otherwise expressly
provided herein (including, but not limited to, <U>Section</U><U></U>&nbsp;6), this Agreement constitutes the entire agreement between Executive and the Company with respect to the subject matter hereof and supersedes any and all prior agreements or
understandings between Executive and the Company with respect to the subject matter hereof, whether written or oral (including, but not limited to, the Employment Agreement). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>11.</B>&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Counterparts</U></B>. This Agreement may be executed and delivered in separate
counterparts, including by &#147;pdf&#148; or other electronic transmission, each of which shall be deemed to be an original and all of which together constitute one and the same agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>12.</B>&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Governing Law</U></B>. The interpretation and enforcement of this Agreement will be
governed by Delaware law, without regard to any conflicts of law provisions contained therein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page Follows] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>Acadia Management Company, LLC.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Christopher H. Hunter</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Christopher H. Hunter</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">President</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>Acadia Healthcare Company, Inc.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Christopher H. Hunter</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Christopher H. Hunter</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Chief Executive Officer</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>EXECUTIVE:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ David Duckworth</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">David Duckworth</TD></TR>
</TABLE></DIV> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Address for the Company:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Acadia Healthcare Company, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Attn: Chris Hunter</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">6100 Tower Circle, Suite
1000</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Franklin, TN 37067</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">chris.hunter@acadiahealthcare.com</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Address for Executive:</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[<I>omitted</I>] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>GENERAL RELEASE </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">I, David Duckworth, in consideration of and subject to the performance by Acadia Management Company, Inc., a Delaware corporation (together
with its subsidiaries and affiliates, the &#147;Company&#148;), of its obligations under the Transition Agreement, dated as of July&nbsp;5, 2023 (the &#147;Agreement&#148;), do hereby release and forever discharge as of the date of my execution or <FONT
STYLE="white-space:nowrap">re-execution,</FONT> as applicable, of this General Release, the Company and its affiliates and all present and former directors, officers, agents, representatives, employees, successors and assigns of the Company and its
affiliates and the Company&#146;s direct and indirect owners (collectively, the &#147;Released Parties&#148;) to the extent provided below. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">I understand that any payments or benefits to which I am entitled under Section&nbsp;4 the Agreement represent, in part, consideration for
signing this General Release and are not salary, wages or benefits to which I was already entitled. I understand and agree that I will not receive the payments and benefits specified in Section&nbsp;4 of the Agreement unless I execute and <FONT
STYLE="white-space:nowrap">re-execute</FONT> this General Release and do not revoke such execution and <FONT STYLE="white-space:nowrap">re-execution</FONT> of this General Release within the time period permitted hereafter and do not breach this
General Release or Section&nbsp;6 of the Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as provided in this paragraph below and except for the provisions of the
Employment Agreement dated April&nbsp;7, 2014 (the &#147;Employment Agreement&#148;) and the Agreement which expressly survive the termination of my employment or service with the Company, I knowingly and voluntarily (for myself, my heirs,
executors, administrators and assigns) release and forever discharge the Company and the other Released Parties from any and all claims, suits, controversies, actions, causes of action, cross-claims, counter-claims, demands, debts, compensatory
damages, liquidated damages, punitive or exemplary damages, other damages, claims for costs and attorneys&#146; fees, or liabilities of any nature whatsoever in law and in equity, both past and present (through the date I execute or <FONT
STYLE="white-space:nowrap">re-execute,</FONT> as applicable, this General Release) and whether known or unknown, suspected, or claimed against the Company or any of the Released Parties which I, my spouse, or any of my heirs, executors,
administrators or assigns, may have, which arise out of or are connected with my employment with, serviced rendered to, or my separation or termination from, the Company (including, but not limited to, any allegation, claim or violation, arising
under: Title VII of the Civil Rights Act of 1964, as amended; the Civil Rights Act of 1991; the Age Discrimination in Employment Act of 1967, as amended (including the Older Workers Benefit Protection Act); the Equal Pay Act of 1963, as amended; the
Americans with Disabilities Act of 1990; the Family and Medical Leave Act of 1993; the Worker Adjustment Retraining and Notification Act; the Employee Retirement Income Security Act of 1974; any applicable Executive Orders; the Fair Labor Standards
Act; or their state or local counterparts; or under any other federal, state or local civil or human rights law, or under any other local, state, or federal law, regulation or ordinance; or under any public policy, contract or tort, or under common
law; or arising under any policies, practices or procedures of the Company; or any claim for wrongful discharge, breach of contract, infliction of emotional distress, defamation; or any claim for costs, fees, or other expenses, including
attorneys&#146; fees incurred in these matters) (all of the foregoing collectively referred to herein as the &#147;Claims&#148;); provided that, this General Release shall not apply to or affect or impair (i)&nbsp;Claims for vested benefits pursuant
to any Company employee benefit plan in which I was a participant prior to the termination of my employment with the Company; (ii)&nbsp;any Claims for unemployment insurance benefits or workers&#146; compensation benefits
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit (cont&#146;d) </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
applicable to the period through the termination of my employment with the Company; or (iii)&nbsp;any Claims that may arise for my indemnification under any directors and officers or similar
insurance, or under the certificate of incorporation, bylaws, limited liability company agreement, certificate of formation and/or other applicable governing documents of the Company, its subsidiaries and/or affiliates. Additionally, notwithstanding
Section&nbsp;6(a) of the Agreement, I agree and acknowledge that the duration of the <FONT STYLE="white-space:nowrap">&#147;Non-Disparagement</FONT> Period&#148; set forth in Section&nbsp;7(c) of the Employment Agreement is hereby amended to last
during the Employment Period (as defined in the Employment Agreement) and at all times thereafter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">I represent that I have made no
assignment or transfer of any right, claim, demand, cause of action, or other matter covered by paragraph 2 above. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">I agree that this
General Release does not waive or release any rights or claims that I may have under the Age Discrimination in Employment Act of 1967 which arise after the date I execute or <FONT STYLE="white-space:nowrap">re-execute,</FONT> as applicable, this
General Release). I acknowledge and agree that my separation from employment and service with the Company is in compliance with the terms of the Employment Agreement, the Agreement and company policy and shall not serve as the basis for any Claim
(including, without limitation, any claim under the Age Discrimination in Employment Act of 1967). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">I agree that I am waiving all rights
to sue or obtain equitable, remedial or punitive relief from any or all Released Parties of any kind whatsoever, including, without limitation, reinstatement, back pay, front pay, attorneys&#146; fees and any form of injunctive relief.
Notwithstanding the above, I further acknowledge that I am not waiving and am not being required to waive any right that cannot be waived under applicable law, including the right to file an administrative charge or participate in an administrative
investigation or proceeding; provided, however, that I disclaim and waive any right to share or participate in any monetary award resulting from the prosecution of such charge or investigation or proceeding, excepting any benefit or remedy to which
I am entitled pursuant to Section&nbsp;922 of the Dodd-Frank Wall Street Reform and Consumer Protection Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In signing this General
Release, I acknowledge and intend that it shall be effective as a bar to each and every one of the Claims hereinabove mentioned. I expressly consent that this General Release shall be given full force and effect according to each and all of its
express terms and provisions, including those relating to unknown and unsuspected Claims (notwithstanding any state statute that expressly limits the effectiveness of a general release of unknown, unsuspected and unanticipated Claims), if any, as
well as those relating to any other Claims hereinabove mentioned. I acknowledge and agree that this waiver is an essential and material term of this General Release and that without such waiver the Company would not have agreed to the terms of the
Agreement. I further agree that in the event I should bring a Claim seeking damages against the Company, or in the event I should seek to recover against the Company in any Claim brought by a governmental agency on my behalf, this General Release
shall serve as a complete defense to such Claims to the maximum extent permitted by applicable law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Nothing in the Employment Agreement,
the Agreement or this General Release shall prohibit or restrict me or my attorneys from: (i)&nbsp;making any disclosure of relevant and necessary information </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit (cont&#146;d) </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
or documents in any action, investigation, or proceeding relating to this General Release, or as required by law or legal process, including with respect to possible violations of law;
(ii)&nbsp;participating, cooperating, or testifying in any action, investigation, or proceeding with, or providing information to, any governmental agency or legislative body, any self-regulatory organization, and/or pursuant to the Sarbanes-Oxley
Act; (iii)&nbsp;accepting any U.S. Securities and Exchange Commission awards; or (iv)&nbsp;initiating communications with, or responding to any inquiry from, any regulatory or supervisory authority regarding any good faith concerns about possible
violations of law or regulation. Pursuant to 18 U.S.C. &#167; 1833(b), I will not be held criminally or civilly liable under any Federal or state trade secret law for the disclosure of a trade secret of the Company that (A)&nbsp;is made (x)&nbsp;in
confidence to a Federal, state, or local government official, either directly or indirectly, or to my attorney and (y)&nbsp;solely for the purpose of reporting or investigating a suspected violation of law; or (B)&nbsp;is made in a complaint or
other document that is filed under seal in a lawsuit or other proceeding. If I file a lawsuit for retaliation by the Company for reporting a suspected violation of law, I may disclose the trade secret to my attorney and use the trade secret
information in the court proceeding, if I file any document containing the trade secret under seal, and do not disclose the trade secret, except pursuant to court order. Nothing in this General Release is intended to conflict with 18 U.S.C. &#167;
1833(b) or create liability for disclosures of trade secrets that are expressly allowed by such section. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">I represent that I am not aware
of any pending charge or complaint of the type described in paragraph 2 above as of the execution or <FONT STYLE="white-space:nowrap">re-execution,</FONT> as applicable, of this General Release. I represent that I am not aware of any claim by me
other than the claims that are released by this General Release. I acknowledge that I may hereafter discover claims or facts in addition to or different than those which I now know or believe to exist with respect to the subject matter of the
release set forth in paragraph 2 above and which, if known or suspected at the time of executing or <FONT STYLE="white-space:nowrap">re-executing,</FONT> as applicable, this General Release, may have materially affected this General Release and my
decision to enter into it. Nevertheless, I hereby waive any right, claim or cause of action that might arise as a result of such different or additional claims or facts. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">I agree that I will forfeit all amounts payable by the Company pursuant to Section&nbsp;4 the Agreement if I challenge the validity of this
General Release. I also agree that if I violate this General Release by suing the Company or the other Released Parties, I will pay all costs and expenses of defending against the suit incurred by the Released Parties, including reasonable
attorneys&#146; fees, and upon the Company&#146;s request return all payments theretofore received by me pursuant to Section&nbsp;4 of the Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Whenever possible, each provision of this General Release will be interpreted in, such manner as to be effective and valid under applicable
law, but if any provision of this General Release is held to be invalid, illegal or unenforceable in any respect under any applicable law or rule in any jurisdiction, such invalidity, illegality or unenforceability will not affect any other
provision or any other jurisdiction, but this General Release will be reformed, construed and enforced in such jurisdiction as if such invalid, illegal or unenforceable provision had never been contained herein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Released Parties are intended to be third-party beneficiaries of this General Release, and this General Release may be enforced by each of
them in accordance with the terms hereof in respect of the rights granted to such Released Parties hereunder. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit (cont&#146;d) </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;12 of the Agreement (&#147;Governing Law&#148;) is incorporated herein and all
references to the Agreement shall be to this General Release. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BY SIGNING THIS GENERAL RELEASE, I REPRESENT AND AGREE THAT: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I HAVE READ IT CAREFULLY; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I UNDERSTAND ALL OF ITS TERMS AND
KNOW THAT I AM GIVING UP IMPORTANT RIGHTS, INCLUDING BUT NOT LIMITED TO, RIGHTS UNDER THE AGE DISCRIMINATION IN EMPLOYMENT ACT OF 1967, AS AMENDED, TITLE VII OF THE CIVIL RIGHTS ACT OF 1964, AS AMENDED; THE EQUAL PAY ACT OF 1963, THE AMERICANS WITH
DISABILITIES ACT OF 1990; AND THE EMPLOYEE RETIREMENT INCOME SECURITY ACT OF 1974, AS AMENDED; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I VOLUNTARILY CONSENT TO EVERYTHING IN IT IN EXCHANGE FOR
GOOD AND VALUABLE CONSIDERATION TO WHICH I WOULD NOT BE ENTITLED IN THE ABSENCE OF EXECUTING, <FONT STYLE="white-space:nowrap">RE-EXECUTING</FONT> AND NOT REVOKING THIS GENERAL RELEASE; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I HAVE BEEN ADVISED TO CONSULT WITH AN ATTORNEY BEFORE EXECUTING IT AND I HAVE DONE SO OR, AFTER CAREFUL READING AND CONSIDERATION, I HAVE CHOSEN NOT TO DO SO
OF MY OWN VOLITION; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I HAVE HAD AT LEAST 21 DAYS FROM THE DATE OF MY FIRST RECEIPT OF THIS GENERAL RELEASE TO CONSIDER IT (ALTHOUGH I MAY SIGN IT SOONER)
AND ANY CHANGES (EITHER MATERIAL OR IMMATERIAL) MADE TO THIS GENERAL RELEASE WILL NOT RESTART THE REQUIRED <FONT STYLE="white-space:nowrap">21-DAY</FONT> PERIOD; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I UNDERSTAND THAT I HAVE SEVEN DAYS AFTER THE INITIAL EXECUTION OF THIS GENERAL RELEASE TO REVOKE IT AND THAT THIS GENERAL RELEASE SHALL NOT BECOME EFFECTIVE
OR ENFORCEABLE UNTIL THE REVOCATION PERIOD HAS EXPIRED; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I UNDERSTAND THAT IF I DO NOT SIGN THIS GENERAL RELEASE OR IF I REVOKE MY INITIAL EXECUTION OF
THIS GENERAL RELEASE, THE GENERAL RELEASE WILL BE VOID AND OF NO FORCE AND EFFECT AND NEITHER MYSELF NOR THE COMPANY WILL HAVE ANY RIGHTS OR OBLIGATIONS UNDER THE AGREEMENT OR THIS GENERAL RELEASE; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I UNDERSTAND THAT I HAVE SEVEN DAYS AFTER MY <FONT STYLE="white-space:nowrap">RE-EXECUTION</FONT> OF THIS GENERAL RELEASE TO REVOKE SUCH <FONT
STYLE="white-space:nowrap">RE-EXECUTION</FONT> AND THAT THIS THAT THE <FONT STYLE="white-space:nowrap">RE-EXECUTION</FONT> OF THIS RELEASE WILL NOT BECOME EFFECTIVE OR ENFORCEABLE UNTIL SUCH REVOCATION PERIOD HAS EXPIRED; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit (cont&#146;d) </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">THE <FONT STYLE="white-space:nowrap">RE-EXECUTION</FONT> OF THIS GENERAL RELEASE WILL ADVANCE THE RELEASE IN
PARAGRAPH 2 ABOVE TO THE SECOND EXECUTION DATE; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IF I DO NOT <FONT STYLE="white-space:nowrap">RE-EXECUTION</FONT> THIS GENERAL RELEASE OR IF I REVOKE MY <FONT
STYLE="white-space:nowrap">RE-EXECUTION</FONT> AS PROVIDED ABOVE, THIS RELEASE SHALL REMAIN IN FULL FORCE AND EFFECT, INCLUDING BUT NOT LIMITED TO THE RELEASE IN PARAGRAPH 2, THROUGH THE FIRST EXECUTION DATE; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I HAVE EXECUTED OR <FONT STYLE="white-space:nowrap">RE-EXECUTED,</FONT> AS APPLICABLE, THIS GENERAL RELEASE KNOWINGLY AND VOLUNTARILY AND WITH THE ADVICE OF
ANY COUNSEL RETAINED TO ADVISE ME WITH RESPECT TO IT; AND </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I AGREE THAT THE PROVISIONS OF THIS GENERAL RELEASE MAY NOT BE AMENDED, WAIVED, CHANGED OR
MODIFIED EXCEPT BY AN INSTRUMENT IN WRITING SIGNED BY AN AUTHORIZED REPRESENTATIVE OF THE COMPANY AND BY ME. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">AGREED AND ACKNOWLEDGED</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>EXECUTIVE:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; ">
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:1pt;border-bottom:1px solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">David Duckworth</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date: __________</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>NOT TO BE <FONT STYLE="white-space:nowrap">RE-EXECUTED</FONT> PRIOR TO THE EXPIRATION OF THE CONSULTING ADVISORY PERIOD</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="white-space:nowrap">RE-EXECUTED</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>EXECUTIVE:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; ">
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:1pt;border-bottom:1px solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">David Duckworth</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:__________</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>4
<FILENAME>d434500dex103.htm
<DESCRIPTION>EX-10.3
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.3</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.3 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B></B><B><I>Execution Version</I></B><B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>SEPARATION AND CONSULTING AGREEMENT </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Separation Agreement (this &#147;<U>Agreement</U>&#148;), dated June&nbsp;28, 2023, is effective as of the &#147;Effective Date&#148; (as
defined below), between Acadia Management Company, Inc. (the &#147;<U>Company</U>&#148;) and Laurence Harrod (&#147;<U>Employee</U>&#148; and with the Company, collectively, the &#147;<U>Parties</U>&#148;). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>W</U> <U>I</U> <U>T</U> N <U>E</U> <U>S</U> <U>S</U> <U>E</U> <U>T</U> <U>H</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, Employee is employed by the Company pursuant to an Employment Agreement, dated August&nbsp;6, 2019, between the Company and Employee
(the &#147;<U>Employment Agreement</U>&#148;); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, Employee has notified the Company that Employee intends to voluntarily resign
from his employment with the Company on June&nbsp;30, 2023, after which date, Employee shall provide Consulting Advisory Service (as defined below) to the Company as provided under this Agreement; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Parties wish to resolve all matters that Employee may have related to Employee&#146;s employment and the termination of
Employee&#146;s employment and consulting services. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NOW, THEREFORE, in consideration of the premises and the releases, representations,
covenants and obligations herein contained, the Parties, intending to be legally bound, hereby agree as follows: </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Cessation of Employment Relationship; Final Pay; COBRA</U></B>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;Employee&#146;s employment as Executive Vice President of Finance of the Company, as well as from all other officer,
director and employment positions that Employee held at or through the Company, and any of its parents, subsidiaries or affiliates, shall cease effective as of June&nbsp;30, 2023, or such earlier date as determined by the Company in its sole
discretion (the &#147;<U>Employment Separation Date</U>&#148;). Employee agrees to promptly execute such additional documentation as requested by the Company to effectuate the foregoing. The Employment Separation Date will be the termination date of
Employee&#146;s employment for purposes of Employee&#146;s active participation in and coverage under all benefit plans and programs sponsored by or through the Company or its affiliates, except as otherwise required by applicable law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;Regardless of whether Employee executes this Agreement, the Company shall timely pay to Employee, minus applicable
withholdings and authorized or required deductions: (i)&nbsp;all earned, but unpaid, wages and accrued, but unused, vacation time earned in accordance with applicable law and Company policy through the Employment Separation Date; (ii)&nbsp;any
unpaid expenses or other reimbursements, due to Employee under the Company&#146;s policies, provided that Employee must submit for reimbursement any outstanding business-related expenses within ten (10)&nbsp;days following the Employment Separation
Date; and (iii)&nbsp;any amounts payable under the Company&#146;s applicable employee benefits plans and programs in accordance with their terms, including, without limitation, under the Company&#146;s Nonqualified Deferred Compensation Plan. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B></B><B><I>Execution Version</I></B><B> </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;Employee will receive under separate cover information regarding
Employee&#146;s rights under the Consolidated Omnibus Budget Reconciliation Act and, if applicable, any state continuation coverage laws (collectively, &#147;<U>COBRA</U>&#148;). Employee acknowledges that Employee should review the COBRA notice and
election forms carefully to understand Employee&#146;s rights and obligations to make timely elections, provide timely notification and make timely premium payments. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Consulting Advisory Services</U></B>. During the period following the Employment Separation Date and ending on
December&nbsp;31, 2023 or such prior date as determined by the Company in its sole discretion upon notice to Employee (the &#147;<U>Consulting Advisory Period</U>&#148;), Employee shall make himself available to provide transition advisory services
as reasonably requested by the Company&#146;s new Executive Vice President and General Counsel, the Company&#146;s Chief Executive Officer or Board of Acadia Healthcare Company, Inc. (the &#147;<U>Consulting Advisory Services</U>&#148;). Employee
will provide the Consulting Advisory Services for no more than 30 hours per month. During the Consulting Advisory Period, in consideration of Employee&#146;s Consulting Advisory Services, continued compliance with the terms and conditions of this
Agreement (including, without limitation, Section&nbsp;5), the discharge of Employee&#146;s duties as Executive Vice President and General Counsel, and the timely execution of the ADEA Release in accordance with this Agreement, Employee shall be
paid $10,309.87 per month, in accordance with the Company&#146;s standard payroll practices. With respect to services rendered during the Consulting Advisory Period, Employee relationship to the Company will only be that of any independent
contractor and, as an independent contractor, Employee agrees to pay in a timely manner all social security and other payroll taxes relating to such compensation. The sole compensation Employee will receive for services during the Consulting
Advisory Period is set forth in this Section&nbsp;2 and Section&nbsp;3 below. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Separation Payment</U></B>.
Provided that Employee complies with this Agreement and the &#147;ADEA Release&#148; (as defined below) becomes effective pursuant to its terms, Employee shall remain eligible to earn a prorated portion of Employee&#146;s annual bonus for the 2023
calendar year based on the number of calendar days between January&nbsp;1, 2023 and the Employment Separation Date, such amount, if any, to be determined and paid in accordance with Section&nbsp;3(c) of the Employment Agreement at the same time such
annual bonuses are paid to other employees of the Company, less all applicable withholdings and authorized or required deductions. The payments under this Section&nbsp;3 are not earnings or wages under any Company 401(k) plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Confidentiality</U></B>. Subject to Section&nbsp;12 below, Employee agrees that the terms and conditions of
this Agreement; the circumstances of Employee&#146;s separation from the Company; all nonpublic, confidential, proprietary and trade secret information that Employee obtained or developed as result of Employee&#146;s employment with the Company; and
any events relating to the Company and/or the Company&#146;s employees that occurred during Employee&#146;s employment with the Company are strictly confidential, except that Employee may disclose the terms and conditions to Employee&#146;s
attorneys, accountants, tax consultants, state and federal tax authorities or as may otherwise be required by law (provided such parties are instructed to comply with this section). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Continuing Obligations</U></B>. Employee hereby reaffirms Employee&#146;s obligations under the Employment
Agreement and agrees to comply at all times with Employee&#146;s post-employment obligations. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B></B><B><I>Execution Version</I></B><B> </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Release</U></B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;In exchange for the consideration provided in this Agreement, Employee agrees that, to the maximum extent permitted
by law, Employee, on behalf of Employee, and Employee&#146;s heirs, beneficiaries, administrators, executors, trustees and assigns, shall, and hereby does, forever and irrevocably release and discharge the Company and each of its past, present and
future parents, subsidiaries, affiliates, portfolio companies and funds, and each of their past, present and future owners, officers, directors, employees, independent contractors, agents, affiliates, parents, subsidiaries, divisions, insurers,
attorneys, predecessors, employee benefit plans, purchasers, assigns, representatives, successors and successors in interest (collectively, the &#147;<U>Released Parties</U>&#148;) from any and all claims, suits, controversies, actions, causes of
action, cross-claims, counter claims, demands, debts, compensatory damages, liquidated damages, punitive or exemplary damages, other damages, claims for costs and attorneys&#146; fees, or liabilities of any nature whatsoever in law and in equity,
both past and present and whether known or unknown, suspected, unsuspected or claimed (collectively, &#147;<U>Claims</U>&#148;) against the Released Parties which Employee or any of Employee&#146;s heirs, executors, administrators or assigns, may
have (i)&nbsp;from the beginning of time through the date upon which Employee executes or <FONT STYLE="white-space:nowrap">re-executes</FONT> (as applicable) this Agreement; (ii)&nbsp;arising out of, or relating to, Employee&#146;s employment with
or services rendered to any Released Parties; (iii)&nbsp;arising out of, or relating to, any agreement and/or any awards, policies, plans, programs or practices of the Released Parties that may apply to Employee or in which Employee may participate,
including, but not limited to, any rights under bonus plans or programs of Released Parties and/or any other short-term or long-term equity-based or cash-based incentive plans or programs of the Released Parties; (iv)&nbsp;arising out of, or
relating to, Employee&#146;s termination of employment or services from any of the Released Parties; and/or (v)&nbsp;arising out of, or relating to, Employee&#146;s status as an employee, member, officer, director or consultant of any of the
Released Parties, including, but not limited to, any allegation, Claim or violation, arising under any federal, state or local civil or human rights law, or under any other local, state, or federal law, regulation or ordinance; or under any public
policy, contract or tort, or under common law; or arising under any policies, practices or procedures of the Company; or any Claim for wrongful discharge, breach of contract, infliction of emotional distress, defamation; or any Claim for costs,
fees, or other expenses, including attorneys&#146; fees incurred in these matters. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding anything in
this Agreement to the contrary, Employee&#146;s release of Claims under the Age Discrimination in Employment Act, as amended (the &#147;<U>ADEA Release</U>&#148;) shall only become effective (i)&nbsp;with respect to Employee&#146;s release of Claims
under the ADEA as of the Effective Date upon: (x)&nbsp;Employee&#146;s initial separate signature set forth on the signature page of this Agreement reflecting Employee&#146;s assent to Employee&#146;s release of Claims under the ADEA as of the
Effective Date and (y)&nbsp;Employee not revoking such execution by the seventh (7th) calendar day following such execution; and (ii)&nbsp;with respect to Employee&#146;s release of Claims under the ADEA as of the date that Employee <FONT
STYLE="white-space:nowrap">re-executes</FONT> this Agreement upon: (x)&nbsp;Employee&#146;s second separate signature set forth on the signature page of this Agreement reflecting Employee&#146;s assent to Employee&#146;s release of Claims under the
ADEA as of the date of such <FONT STYLE="white-space:nowrap">re-execution</FONT> and (y)&nbsp;the occurrence of the ADEA Release Effective Date (as defined below). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;Employee represents and agrees that Employee has not, by himself/herself or on Employee&#146;s behalf, instituted,
prosecuted, filed, or processed any litigation, Claims or proceedings against the Company or any Released Parties, nor has Employee encouraged or </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B></B><B><I>Execution Version</I></B><B> </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
assisted anyone to institute, prosecute, file, or process any litigation, Claims or proceedings against the Company or any Released Parties. Nothing in this Section&nbsp;6 shall release or impair
(i)&nbsp;any Claim or right that may arise after the date that Employee executes or <FONT STYLE="white-space:nowrap">re-executes</FONT> (as applicable) this Agreement; (ii)&nbsp;any right to any earned and accrued base salary, vacation or benefits
or incurred but unreimbursed business expense reimbursements or any severance or other benefits to which Employee is entitled under this Agreement (including, without limitation, Section&nbsp;1 of this Agreement, which it is acknowledged Employee is
entitled to receive as provided herein), (iii) any rights to vested ERISA benefits, as well as Employee&#146;s rights as an equity or security holder in the Company or its affiliates; (iv)&nbsp;any Claim or right Employee may have pursuant to
indemnification, advancement, defense, or reimbursement pursuant to any applicable D&amp;O policies, any similar insurance policies, applicable law or otherwise; and (v)&nbsp;any Claim which by Federal, state or local law cannot be waived. Nothing
in this Agreement is intended to prohibit or restrict Employee&#146;s right to file a charge with or participate in a charge by the Equal Employment Opportunity Commission, or any other local, state, or federal administrative body or government
agency; provided that Employee hereby waives the right to recover any monetary damages or other relief against any Released Parties; <U>provided</U>, <U>however</U>, that nothing in this Agreement shall prohibit Employee from receiving any monetary
award to which Employee becomes entitled pursuant to Section&nbsp;922 of the Dodd-Frank Wall Street Reform and Consumer Protection Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;Employee understands that Employee may later discover Claims or facts that may be different than, or in addition
to, those which Employee now knows or believes to exist with regards to the subject matter of this Agreement, and which, if known at the time of executing or <FONT STYLE="white-space:nowrap">re-executing</FONT> (as applicable) this Agreement, may
have materially affected this Agreement or Employee&#146;s decision to enter into it. Employee hereby waives any right or Claim that might arise as a result of such different or additional Claims or facts. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;Employee represents that Employee has made no assignment or transfer of any right or Claim covered by this
Section&nbsp;6 and that Employee further agrees that Employee is not aware of any such right or Claim covered by this Section&nbsp;6. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;Employee understands, acknowledges, and agrees that any amounts paid to him in accordance with Section&nbsp;3 of
this Agreement exceed what Employee is otherwise entitled to receive upon separation from employment due to Employee&#146;s voluntary resignation, and that these benefits are being given as consideration in exchange for executing this Agreement,
including the ADEA Release contained in it. Employee understands that he will not receive any payments specified in Section&nbsp;3 unless Employee executes this Agreement including the ADEA Release contained in it,
<FONT STYLE="white-space:nowrap">re-executes</FONT> this Agreement for purposes of the ADEA Release, and does not revoke the execution and <FONT STYLE="white-space:nowrap">re-execution</FONT> of the ADEA Release within the time period permitted
hereafter and thereafter. Employee acknowledges and agrees that, except as expressly set forth under this Agreement, Employee is not entitled to receive any additional compensation, bonus, equity compensation, payment in lieu of any paid time off,
equity awards, severance payments or other payments or benefits of any kind from the Company or its parents, subsidiaries or its affiliates or with respect to Employee&#146;s employment with the Company or any of its parents, subsidiaries and
affiliates, including, without limitation, any payments of any kind under the Employment Agreement. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B></B><B><I>Execution Version</I></B><B> </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g)&nbsp;&nbsp;&nbsp;&nbsp;In signing or <FONT STYLE="white-space:nowrap">re-signing</FONT>
(as applicable) the ADEA Release, Employee acknowledges and intends that it will be effective as a bar to each and every one of the released Claims hereinabove mentioned or implied. Employee expressly consents that the ADEA Release will be given
full force and effect according to each and all of its express terms and provisions, including those relating to unknown and unsuspected released Claims (not withstanding any state or local statute that expressly limits the effectiveness of a
general release of unknown, unsuspected and unanticipated claims), if any, as well as those relating to any other released Claims hereinabove mentioned or implied. Employee acknowledges and agrees that this waiver is an essential and material term
of the ADEA Release and that without such waiver the Company would not have agreed to the terms of this Agreement. Employee further agrees that in the event Employee should seek to recover against the Company in any released Claim brought by a
governmental agency on Employee&#146;s behalf, the ADEA Release will serve as a complete defense to such released Claim to the maximum extent permitted by law. Employee further agrees that he is not aware of any pending claim of the type described
in Section&nbsp;6(a) above as of the execution and <FONT STYLE="white-space:nowrap">re-execution</FONT> (as applicable) of the ADEA Release. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.&nbsp;&nbsp;&nbsp;&nbsp;<B><U>No Cooperation with <FONT STYLE="white-space:nowrap">Non-Governmental</FONT> Third Parties</U></B>. Employee
agrees that, to the maximum extent permitted by law, Employee will not encourage or voluntarily assist or aid in any way any <FONT STYLE="white-space:nowrap">non-governmental</FONT> attorneys or their clients or individuals acting on their own
behalf in making or filing any lawsuits, complaints, or other proceedings against the Company or any other Released Parties, and represents that Employee has not previously engaged in any such conduct. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Company Property</U></B>. Employee acknowledges and agrees that, other than as expressly approved by the
Company and necessary for the provision of the Consulting Advisory Services, Employee has returned, or will return within two (2)&nbsp;days after the Employment Separation Date, all Company property and
<FONT STYLE="white-space:nowrap">non-public,</FONT> confidential, proprietary and/or trade secret information in Employee&#146;s custody, possession or control, in any form whatsoever, including without limitation, equipment, telephones, smart
phones, work-related passwords; PDAs, laptops, credit cards, keys, access cards, identification cards, security devices, network access devices, pagers, confidential or proprietary information, documents, manuals, reports, books, compilations, work
product, <FONT STYLE="white-space:nowrap">e-mail</FONT> messages, recordings, tapes, removable storage devices, hard drives, computers and computer discs, files and data (collectively, &#147;<U>Company Property</U>&#148;), which Employee prepared or
obtained during the course of Employee&#146;s employment with the Company. If Employee discovers any property of the Company or <FONT STYLE="white-space:nowrap">non-public,</FONT> confidential, proprietary and/or trade secret information in
Employee&#146;s possession after the Effective Date, Employee shall promptly return such property to the Company or, at the instruction of the Company, destroy such property or information. Notwithstanding the foregoing, Employee further
acknowledges and agrees that Employee will return within two (2)&nbsp;days after the expiration of the Consulting Advisory Period any Company Property obtained during the Consulting Advisory Period or retained for use during the Consulting Advisory
Period with express approval by the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.&nbsp;&nbsp;&nbsp;&nbsp;<B><U>No Admission of Liability; No Prevailing Party</U></B>. The
Parties agree that this Agreement is not to be construed as an admission of any wrongdoing or liability on the part of the Parties under any statute or otherwise, but that on the contrary, any such wrongdoing or liability is expressly denied by the
Parties. The Parties agree that neither this Agreement nor the </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B></B><B><I>Execution Version</I></B><B> </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
negotiations in pursuance thereof shall be construed or interpreted to render the Parties a prevailing party for any reason, including but not limited to an award of attorney&#146;s fees,
expenses or costs under any statute or otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Voluntary Execution</U></B>. Employee acknowledges,
certifies and agrees that: (a)&nbsp;Employee has carefully read this Agreement and fully understands all of its terms; (b)&nbsp;Employee had a reasonable amount of time to consider Employee&#146;s decision to execute or <FONT
STYLE="white-space:nowrap">re-execute</FONT> (as applicable) this Agreement; (c)&nbsp;in executing or <FONT STYLE="white-space:nowrap">re-executing</FONT> (as applicable) this Agreement Employee does not rely and has not relied upon any
representation or statement made by any of the Company&#146;s agents, representatives, or attorneys with regard to the subject matter, basis, or effect of the Agreement; and (d)&nbsp;that Employee enters into this Agreement voluntarily, of
Employee&#146;s own free will, without any duress and with knowledge of its meaning and effect in exchange for good and valuable consideration to which Employee would not be entitled in the absence of executing or
<FONT STYLE="white-space:nowrap">re-executing</FONT> (as applicable) this Agreement and not revoking the ADEA Release. Employee acknowledges that the Company has advised Employee to consult with an attorney prior to executing or <FONT
STYLE="white-space:nowrap">re-executing</FONT> (as applicable) this Agreement and that Employee has had an opportunity to consult with Employee&#146;s counsel. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Review Period</U></B>. Employee has been given <FONT STYLE="white-space:nowrap">twenty-one</FONT>
(21)&nbsp;days from the date of Employee&#146;s receipt of this Agreement to consider the terms of this Agreement, although Employee may sign it at any time sooner; provided, that Employee may not <FONT STYLE="white-space:nowrap">re-execute</FONT>
the ADEA Release until the expiration of the Consulting Advisory Period. The Parties agree that any revisions or modifications to this Agreement, whether material or immaterial, will not and did not restart this time period. The first date upon
which Employee and the Company have signed this Agreement and the Company has received Employee&#146;s signature, shall be the &#147;<U>Effective Date</U>&#148;. Employee has seven (7)&nbsp;calendar days after the date on which Employee initially
executes this Agreement for purposes of the ADEA Release to revoke Employee&#146;s consent to the ADEA Release. If Employee does not sign this Agreement for purposes of the ADEA Release or if Employee revokes Employee&#146;s first execution of this
Agreement for purposes of the ADEA Release, the ADEA Release shall be null and void and the &#147;ADEA Release Effective Date&#148; (as defined below) shall not occur. Provided that Employee does not revoke Employee&#146;s first execution of this
Agreement for purposes of the ADEA Release within such seven (7)&nbsp;day revocation period, this ADEA Release will become effective on the eighth (8th) calendar day after the date on which Employee signs this Agreement for purposes of the ADEA
Release. Employee&#146;s <FONT STYLE="white-space:nowrap">re-execution</FONT> of the ADEA Release advances the ADEA Release to the date of such <FONT STYLE="white-space:nowrap">re-execution.</FONT> After such
<FONT STYLE="white-space:nowrap">re-execution,</FONT> Employee has seven (7)&nbsp;calendar days to revoke Employee&#146;s consent to the advancement of the ADEA Release to the date of such <FONT STYLE="white-space:nowrap">re-execution.</FONT>
Provided that Employee does not revoke Employee&#146;s <FONT STYLE="white-space:nowrap">re-execution</FONT> of the ADEA Release within such seven (7)&nbsp;day revocation period, the ADEA Release will advance to the date of such <FONT
STYLE="white-space:nowrap">re-execution</FONT> effective on the eighth (8th) calendar day after the date on which Employee <FONT STYLE="white-space:nowrap">re-executes</FONT> the ADEA Release (the &#147;<U>ADEA Release Effective Date</U>&#148;). If
Employee does not <FONT STYLE="white-space:nowrap">re-execute</FONT> the ADEA Release or if Employee revokes Employee&#146;s <FONT STYLE="white-space:nowrap">re-execution</FONT> of the ADEA Release, the Company&#146;s obligations under
Section&nbsp;3 of this Agreement shall be null and void; however, the ADEA Release will remain in full force and effect through the Effective Date. For purposes of the foregoing, any revocation must be in writing and must be emailed to Chris Hunter
at Chris.Hunter@acadiahealthcare.com, and notice of such revocation must be received within the applicable seven (7)&nbsp;calendar days referenced above. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B></B><B><I>Execution Version</I></B><B> </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12.&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Permitted Disclosures</U></B>. Nothing in this Agreement or
any other agreement between the Parties or any other policies of the Company or its affiliates shall prohibit or restrict Employee or Employee&#146;s attorneys from: (a)&nbsp;making any disclosure of relevant and necessary information or documents
in any action, investigation, or proceeding relating to this Agreement, or as required by law or legal process, including with respect to possible violations of law; (b)&nbsp;participating, cooperating, or testifying in any action, investigation, or
proceeding with, or providing information to, any governmental agency or legislative body, any self-regulatory organization, and/or pursuant to the Sarbanes-Oxley Act; or (c)&nbsp;accepting any U.S. Securities and Exchange Commission awards. In
addition, nothing in this Agreement or any other agreement between the Parties or any other policies of the Company or its affiliates prohibits or restricts Employee from initiating communications with, or responding to any inquiry from, any
regulatory or supervisory authority regarding any good faith concerns about possible violations of law or regulation. Pursuant to 18 U.S.C. &#167; 1833(b), Employee will not be held criminally or civilly liable under any Federal or state trade
secret law for the disclosure of a trade secret of the Company or its affiliates that (i)&nbsp;is made (x)&nbsp;in confidence to a Federal, state, or local government official, either directly or indirectly, or to Employee&#146;s attorney and
(y)&nbsp;solely for the purpose of reporting or investigating a suspected violation of law; or (ii)&nbsp;is made in a complaint or other document that is filed under seal in a lawsuit or other proceeding. If Employee files a lawsuit for retaliation
by the Company for reporting a suspected violation of law, Employee may disclose the trade secret to Employee&#146;s attorney and use the trade secret information in the court proceeding, if Employee files any document containing the trade secret
under seal, and does not disclose the trade secret, except pursuant to court order. Nothing in this Agreement or any other agreement between the Parties or any other policies of the Company or its affiliates is intended to conflict with 18 U.S.C.
&#167; 1833(b) or create liability for disclosures of trade secrets that are expressly allowed by such section. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13.&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Successors and Assigns; Third-Party Beneficiaries</U></B>. The Parties agree that this Agreement shall inure
to the benefit of the personal representatives, heirs, executors, and administrators of Employee. This Agreement may not be assigned by Employee. The Company may freely assign all rights and obligations of this Agreement to any affiliate or
successor (including to a purchaser of assets). The Released Parties are expressly intended to be third-party beneficiaries of this Agreement and it may be enforced by each of them. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14.&nbsp;&nbsp;&nbsp;&nbsp;<B><U>No Oral Modifications</U></B>. This Agreement shall not be modified except in writing signed by Employee and
an authorized representative of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15.&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Severability</U></B>. If any terms of the above provisions
of this Agreement are found null, void or inoperative, for any reason, the remaining provisions will remain in full force and effect. The language of all parts of this Agreement shall in all cases be construed as a whole, according to its fair
meaning, and not strictly for or against either of the Parties. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">16.&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Counterparts</U></B>. This Agreement may
be executed in counterparts, each of which will be deemed an original but all of which together will constitute one and the same instrument. An originally executed version of this Agreement that is scanned as an image file (e.g., Adobe PDF, TIF,
etc.) and then delivered by one Party to the other Party via electronic mail as evidence of signature, shall, for all purposes hereof, be deemed an original signature. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B></B><B><I>Execution Version</I></B><B> </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">17.&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Governing Law; Jurisdiction; Waiver of Jury Trial</U></B>.
The Parties agree that this Agreement and the rights and obligations hereunder shall be governed by, and construed in accordance with, the laws of the State of Delaware regardless of any principles of conflicts of laws or choice of laws of any
jurisdiction. The Parties agree that any action between Employee and the Company shall be resolved exclusively in a federal or state court in Tennessee, and the Company and Employee hereby consent to such jurisdiction and waive any objection to the
jurisdiction of any such court. As a specifically bargained for inducement for each of the Parties to enter into this Agreement, Employee and the Company (after having the opportunity to consult with counsel) hereby waive trial by jury as to any and
all litigation arising out of and/or relating to this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">18.&nbsp;&nbsp;&nbsp;&nbsp;<B><U>Entire Agreement</U></B>. This
Agreement and the Employment Agreement constitute the complete and entire agreement and understanding of the Parties, and supersede in their entirety any and all prior understandings, negotiations, commitments, obligations and/or agreements, whether
written or oral, between the Parties. The Parties represent that, in executing or <FONT STYLE="white-space:nowrap">re-executing</FONT> (as applicable) this Agreement, each Party has not relied upon any representation or statement made by the other
Party, other than those set forth in this Agreement, with regard to the subject matter, basis or effect of this Agreement. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B></B><B><I>Execution Version</I></B><B> </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the Parties have duly executed or
<FONT STYLE="white-space:nowrap">re-executed,</FONT> as applicable, this Agreement as of the below-indicated date(s). </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="47%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>EMPLOYEE</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Laurence Harrod</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">June&nbsp;28, 2023</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Laurence Harrod</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Date</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>ACADIA MANAGEMENT COMPANY, LLC</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Christopher H. Hunter</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">June&nbsp;28, 2023</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">(Signature)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Date</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Name: <U>Christopher
Hunter&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;</U></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Title:
<U>President&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>AGREED AND ACKNOWLEDGED</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5"><B><U>WITH RESPECT TO FIRST EXECUTION OF ADEA RELEASE</U></B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>EMPLOYEE</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Laurence Harrod</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">June&nbsp;28, 2023</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Laurence Harrod</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Date</TD></TR>
</TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><B>*</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>NOT TO BE SIGNED PRIOR TO THE EXPIRATION OF THE CONSULTING ADVISORY PERIOD*</B> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>AGREED AND ACKNOWLEDGED <U> </U></B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>WITH RESPECT TO <FONT
STYLE="white-space:nowrap">RE-EXECUTION</FONT> OF ADEA RELEASE</U> </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="47%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>EMPLOYEE</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:1pt;border-bottom:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt;margin-bottom:1pt;border-bottom:1px solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Laurence Harrod</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Date</TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>achc-20230628.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 7/6/2023 1:13:36 AM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2022"
  xmlns:achc="http://www.acadiahealthcare.com/20230628"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.acadiahealthcare.com/20230628"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" namespace="http://xbrl.sec.gov/dei/2022" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2022/naics-2022.xsd" namespace="http://xbrl.sec.gov/naics/2022" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="achc-20230628_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="achc-20230628_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.acadiahealthcare.com//20230628/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>achc-20230628_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 7/6/2023 1:13:36 AM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Two</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>achc-20230628_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 7/6/2023 1:13:36 AM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.acadiahealthcare.com//20230628/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="achc-20230628.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.acadiahealthcare.com//20230628/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="25.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="45.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140029568879712">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Jun. 28, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001520697<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 28,  2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Acadia Healthcare Company, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-35331<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">45-2492228<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">6100 Tower Circle<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 1000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Franklin<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TN<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">37067<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(615)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">861-6000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, $0.01 par value<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ACHC<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>d434500d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="achc-20230628.xsd" xlink:type="simple"/>
    <context id="duration_2023-06-28_to_2023-06-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
        </entity>
        <period>
            <startDate>2023-06-28</startDate>
            <endDate>2023-06-28</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="duration_2023-06-28_to_2023-06-28">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2023-06-28_to_2023-06-28"
      id="Hidden_dei_EntityCentralIndexKey">0001520697</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2023-06-28_to_2023-06-28">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2023-06-28_to_2023-06-28">2023-06-28</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2023-06-28_to_2023-06-28">Acadia Healthcare Company, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2023-06-28_to_2023-06-28">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2023-06-28_to_2023-06-28">001-35331</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2023-06-28_to_2023-06-28">45-2492228</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2023-06-28_to_2023-06-28">6100 Tower Circle</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="duration_2023-06-28_to_2023-06-28">Suite 1000</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="duration_2023-06-28_to_2023-06-28">Franklin</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2023-06-28_to_2023-06-28">TN</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2023-06-28_to_2023-06-28">37067</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2023-06-28_to_2023-06-28">(615)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2023-06-28_to_2023-06-28">861-6000</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2023-06-28_to_2023-06-28">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2023-06-28_to_2023-06-28">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2023-06-28_to_2023-06-28">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2023-06-28_to_2023-06-28">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2023-06-28_to_2023-06-28">Common Stock, $0.01 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2023-06-28_to_2023-06-28">ACHC</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2023-06-28_to_2023-06-28">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2023-06-28_to_2023-06-28">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M='7Y=EXVK,J*-^*ELO!^71QN!(?<=QW@^DHI^]YP+]G5-Y+QOU!+ P04
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MJ'7N0;#W\!J-'<V/'[?\ 5!+ P04    " #=B>56)!Z;HJT   #X 0  &@
M 'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QSM9$]#H,P#(6O$N4 -5"I0P5,
M75@K+A %\R,2$L6N"K<OA0&0.G1ALIXM?^_)3I]H%'=NH+;S)$9K!LIDR^SO
M *1;M(HNSN,P3VH7K.)9A@:\TKUJ$)(HND'8,V2>[IFBG#S^0W1UW6E\./VR
M./ /,+Q=Z*E%9"E*%1KD3,)HMC;!4N++3):BJ#(9BBJ6<%H@XLD@;6E6?;!/
M3K3G>1<W]T6NS>,)KM\,<'AT_@%02P,$%     @ W8GE5F60>9(9 0  SP,
M !,   !;0V]N=&5N=%]4>7!E<UTN>&ULK9--3L,P$(6O$F5;)2XL6*"F&V +
M77 !8T\:J_Z39UK2VS-.VDJ@$A6%3:QXWKS/GI>LWH\1L.B=]=B4'5%\% )5
M!TYB'2)XKK0A.4G\FK8B2K636Q#WR^6#4,$3>*HH>Y3KU3.T<F^I>.EY&TWP
M39G 8ED\C<+,:DH9HS5*$M?%P>L?E.I$J+EST&!G(BY84(JKA%SY'7#J>SM
M2D9#L9&)7J5CE>BM0#I:P'K:XLH90]L:!3JHO>.6&F,"J;$#(&?KT70Q32:>
M,(S/N]G\P68*R,I-"A$YL01_QYTCR=U59"-(9*:O>"&R]>S[04Y;@[Z1S>/]
M#&DWY(%B6.;/^'O&%_\;SO$1PNZ_/[&\UDX:?^:+X3]>?P%02P$"% ,4
M" #=B>56!T%-8H$   "Q    $               @ $     9&]C4')O<',O
M87!P+GAM;%!+ 0(4 Q0    ( -V)Y5::X4T.[P   "L"   1
M  "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( -V)Y5:97)PC
M$ 8  )PG   3              "  <T!  !X;"]T:&5M92]T:&5M93$N>&UL
M4$L! A0#%     @ W8GE5D0B/LE<!   +Q$  !@              ("!#@@
M 'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( -V)Y5:?H!OP
ML0(  .(,   -              "  : ,  !X;"]S='EL97,N>&UL4$L! A0#
M%     @ W8GE5I>*NQS     $P(   L              ( !? \  %]R96QS
M+RYR96QS4$L! A0#%     @ W8GE5APX9>H_ 0  / (   \
M ( !91   'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( -V)Y58D'INBK0
M /@!   :              "  =$1  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN
M<F5L<U!+ 0(4 Q0    ( -V)Y59ED'F2&0$  ,\#   3              "
M ;82  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D /@(    4
!  $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d434500d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.acadiahealthcare.com//20230628/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="d434500d8k.htm">d434500d8k.htm</File>
    <File>achc-20230628.xsd</File>
    <File>achc-20230628_lab.xml</File>
    <File>achc-20230628_pre.xml</File>
    <File>d434500dex101.htm</File>
    <File>d434500dex102.htm</File>
    <File>d434500dex103.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "d434500d8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2022": 23
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "d434500d8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "achc-20230628_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "achc-20230628_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "achc-20230628.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/naics/2022/naics-2022.xsd"
     ]
    }
   },
   "elementCount": 24,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 23,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "achc",
   "nsuri": "http://www.acadiahealthcare.com/20230628",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d434500d8k.htm",
      "contextRef": "duration_2023-06-28_to_2023-06-28",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.acadiahealthcare.com//20230628/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d434500d8k.htm",
      "contextRef": "duration_2023-06-28_to_2023-06-28",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.acadiahealthcare.com//20230628/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.acadiahealthcare.com//20230628/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.acadiahealthcare.com//20230628/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.acadiahealthcare.com//20230628/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.acadiahealthcare.com//20230628/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.acadiahealthcare.com//20230628/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.acadiahealthcare.com//20230628/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.acadiahealthcare.com//20230628/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.acadiahealthcare.com//20230628/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.acadiahealthcare.com//20230628/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.acadiahealthcare.com//20230628/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.acadiahealthcare.com//20230628/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.acadiahealthcare.com//20230628/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.acadiahealthcare.com//20230628/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.acadiahealthcare.com//20230628/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.acadiahealthcare.com//20230628/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.acadiahealthcare.com//20230628/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.acadiahealthcare.com//20230628/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.acadiahealthcare.com//20230628/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.acadiahealthcare.com//20230628/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.acadiahealthcare.com//20230628/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.acadiahealthcare.com//20230628/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.acadiahealthcare.com//20230628/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001193125-23-182040-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-23-182040-xbrl.zip
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MC'(R<(9_(CV1U$B'<]*W,HTN-:AG2&N;J)R)OUKV;62]D[=O"+XPC4+GI>W
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M70HR]4$#D<M'GVJUX]GHL0QU*-I3XB59B9(7^^>I#5B%TY ?P( T0\@H$#)
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MCTG+U9XET_08]UAPQ_.Q4(5W9I_#L,$\2:'YA#2$0!>$K65>\Q)9IX!TL(E
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M"RCB*R]M@H$,4 ^^_<"6I(_534TY" )]"PC75'/6J %)3'4253:9!P\#K6<
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M **7X3!.1L0HB3O:D 1RN66.&-:"@\08O43$: 1'9' )P)(.@7<"NQPA@!(
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M-22P>CRCDG?4ZMZK^6&#E4?>&IDH-P65MPSXDC9;KZ4.Y)2OYK'SS>=3(H1
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M4#.W,;VEIP#5;!$<>2XD[@+&$!:ENEJ0(EK*X3-"^,CAXP-= BPXC?'$_?)
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M? JC4MX.&<RC90/S&5*=IN)<M&% <<R0,7$#YY3&0(:)5^U?&8O 5)VY1#<
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M,SQ*SH0@XO55FSV$M;JIW68G5EV4WN=^=JR/JA4IGW+PG%!+ R"(H6$)*!H
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M6N*&R027@<9O%'D6U,=VV^I=6+ZN>ESZT.0DR_W??WU%0W8#9H,':Z[\??]
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MC'R;*J<4_/[BA>$XQ_%HM'L"<NY+O?8)4?L2+%J-+A!"+80$3;_ D&'>>?,
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M]4(2<+I[_!F^/.V?G[W['U!+ P04    " #=B>56K2^3.@XP   *W   $0
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MF:(5VD?@Z(,P28M\$5\2ZVU'?QKJ.8EI-:>ET]/I<*)'"Q"A^&4:1R#E:3I
M&!"=TRF-;@Z^6@FC83 /AF&V!+-D)PQW<XP$AH#AF6^-%]/I'@TU6I"IA&M!
M+0Q%_@#PE+],RQ0YA+/9(8)+ !+8UX G!("IH..1^I4EBS0C:QA,4@.3:?A1
M&VN3E(@,T"^*=,(J,BS>G,X09@?0DYY8T/LMRE0K= !P.@:V=TF(QX' @36"
M.A.F$P1C/,79TII* *QFVS<+D<2@!-WJ)#+\&G6HQ9!VB!0L%@J^#8H-;I,-
MHQK. K!"7 &. NM!5!G%<[0P\2=8(E@$^ZH_\7D:Z38(X0+#F 7+VAJ^6E-O
MSCKMOJI6C-=L$F9Z+X5#UZ]A34DP?W*<Z+T@19IY\Q0?/F:L38B1S.$8/#5R
M1=G>B VBUWL[<!H>_^QOB:09,4YBI4)T49R17IF%V2(S9/P65<^N#@##F5K5
M#DJO$#A+ "84B*M=-J?PG &T21)$XJ+!?5G&X;- D@AJD.@ EF"V6X(Z]B5O
M'%+^T>TX7^-V7&&>RN>.H(8^$4?->C/B:WHOC7?NP*P<_;"-UCO0*,73"INA
M_V%':;:<ZKS>K&<K2\&OYL&-WD,(?MP;:& =^G4PO0N6Z1/44N<H7<Z[JM?Z
MO["QYT_,N.3N??V/W^F_)^I]J]$__^/)P;-GO]CEGC;;_6;W47S!7U>D#=>*
MM,8B,4R#V;<8+&LT/]9]F/^Q]2..E4U.C1*5"FRCHNVJMI!\VWI>K'9E_".9
M\[(&9M[4N$<"M-61AH';+DFW LYK1[4JKF$U$0"63'=V3[DU&O<4$*;51T5,
MLKM6K&(49D$TU&+NWB\EU'<1$L9]MK64.!-W<' ;AR/:("I^\6*0U63"&3PZ
MM&JKV^YZ=/@JW%<]C/E6*Y_%?3?Y7AY'<QUM0^:E>J= F]61;<ZEANCPYSK7
MU]#.0>@=$C)8%,>36?'UK&K3M!38(V";Y@G$=F%58H,B$<717@*Z\3#@. 1K
M$W*:73T%E,GY6N' V2N*"N!P&"<C?\'^HC:S)*N8D[<)'L'Y3G"R7C!%4Z=D
M? F6B V\$^QNQ#I1,64:9($P>S9E>W&@(]@/D/)\D:2+@#V>A?&U&;]:*9O@
M^^.P7HO#_<UBAESS VTQ+!332VPUV&\12YVKE<T7+XH5<-2 XC'#<,XCA9$@
M+7!1T# ,;Z%I"?)J/@VBU+AM;Y( T)QTT3AA<4(,,HD7-Q-?7M64&%$8MK*<
M2&Q\>F\:W"EAKDP\:&*ABLH3XN)EOA(N7*TX-HSDJ"/QZ@F6T@P.K4?;L0JU
M+:<H%]T>]\!?@SEPB2$Y;Y$J)O&47:O!)_1I]ZT"\:\%:%7C)?ZF;^'@A.][
M"%]RSN+ -W$-=J&#J.1(6F<6A6#<J9,%6 /HW(25#LGA03%9%I 'O__V:XV<
M'BSL_!!4YZ1;S\<FR?=18XR,A\-%<K^6M%\,,@&,0.B%XY BG"3Q2=T:B_TJ
MI$X6"QA>\$VUXM@N[Y66QH&+L4.>FL]V\<<I2,S,.GH)KV0D8E,E3(L&KHG'
MBS%R[9BIW0^YY5/T-92POA<[XXVL;Z-Z4:V0 BO14\^Z8_@\:"+4F$!Y0V"O
MDVL65O88G-*,JH;/?N IC\\P+:0+(! 1#TZTE4M 2S=P#.C\0%;%JJ/1S^Y7
MO*S:&(HJ9=1BLJP#6EI*/!"_&,8I^I#2-!Z&1"'NR.V&O[J;[G.B&8?[&'A8
M&]&@C \,'D_5>V#7Z9%JQZI#.MN5[-D$+_95APDT@B6)RIR WN&YL8#$D%]@
MX,FWCS;9/>L<V3YG]Q@?,/G=E5BST23&QO5HSM+J&HA0, .YQ1?H@YP'(?P3
MM8Z4M0ZR'H;#9('A+'YFD>*_;P/6D-@W)X.LDCMHA;E5TH!F'61S+'-B;3U,
MCCSE!5_6GU ::><*A/V&LP%P<VW%,LE7XY"T+X01L-6D=+GYI1D'$*+]4F=N
M@J+5>.3[[BBF',SB!1(&G#UMW1<@.8O0 X^QHCQE;%4G*%4S=<@VB\B[']65
M<_C3E7,/VWL0FRL&V,0@0G;D&UYLX6Z+K^TX8D4*E8N&'FNBI%-?-[P"K%V#
MITX%18K5\7A_G6<5A2_(9J?= ODFZ$-?NFR3,"I*/?8VE"O">4:TPBV1R W'
M)(B,6">A) .W.\RZ0!V>)*7A/)9@.;1E"5DB61_#J.@;V\#[62#CUN=A/@'"
MI6\XA5D4Y=4TG;60+?JL2Q0'%N7;;MJ>!V=:@.#"P(T6'<'XG^:P3L_C07R;
ML Q#3:@RI28IT5/#BWDU)8'%E62:!RT>%5&.2GI^L3@)IAB-&$X7I,NAW$/T
M(,64[&74C<#>6TU\6J> _@54GN=;J#QE&&;R@ZS"8Y+O[O/_^EF$121?]0*S
MK6U"X>+[A$,V)WR]W]M';7R1N,A,\]-P@HXY1(]9F%*J$V%'%&%R4*(Q](.#
MGF$,\%[?S\&SO7\:CT\1JW")XS =PK!+T';,XAO ,3!H79Z'4*TPUI>G(?AX
MO2:E@)(#T)8;ZCS/7HD'KV$,&UWBL^ C1H!GJ9X"H[H-PBEQ1PR;?IGOFVVJ
MK^#[OG^;/G;*1O=5WF6Y!C3EB68K=MNF26O.6XD6]&>[*W<LKZG97 UG!=?N
M28Q^B9]VV5Q#W)D X]"E>S&13HYG4\B: ]#^08+8!I%K,(%@V.S4+"<NNE7)
M1>0[1S_#$3I  QPLC_]U<%#[]=6+_=]^1XZB9@#<26V=*E% +Q(CB#V@PB0Q
M"1STQ V-$RBO"PTHG1"!#@A+!M)P&@#$?<M=33 '#ZB"7:0H3=)Q@)DHP&*!
MM"6U8!V6V11:+RDV[U&%7Z9HF>1GG &S2#CU@F,)>E1,W'$X5!@0#RF_:N"7
MNI"QZY),Y<RUVQM2 4*85:LD V/Q^3.3,@*Z,U@VG%,LTM+P)M;F<CSJR$K'
M&FMS-N>_S-= &3^YT DPWRP)V9EJTCQS6;0NQ3-<<9'E5,(<D%[N#':5+%<B
M]F3"6E>C"105J0?,=X"J@#./#&I;7-A7[PMRQ7+3!)V#J*J.MF->)3G#+K6R
MF*/-[L0(44K\6J*:HCXQUZ14$"]+:$N(1^RRC##!INR16DE21TRV!;$5X1+"
M7<AQ%5,>?LH2G#4YR2(3@B6/K6R#<V/%G^AT.29EDI(Y=_0ZSP?*80-@@>L&
M)3K,XQ1*,?AJ,_-]3E4I%%JZOWJEQKKY7T(=?+&%.M@'@LQ,R+6SR(RJKIK
MBN ,ZW? <#U/6&^;N-Z/)"F13S#[?IBP+&;>HRF^04*42+AML,[P4\#L+>W$
M]6)\N^AHHO?L&VMBH[F]5"NE\A^?!SWY0%WUKAF)_*".,%-\?P]]D2-U"Z(
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M[>\GF_H?SZ;*N-3*!0\_H(/AGANE 9L[C0_PY7G_\N+XOP%02P,$%     @
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MSVX&9K5.A5,7N)1]4O+9V2M6<!Y$ 7!4;67=B>.?-XFU6<IH044P8!'*>6)
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M."YX<V102P$"% ,4    " #=B>56_$%P,7H&  "X1@  %0
M@ %T P  86-H8RTR,#(S,#8R.%]L86(N>&UL4$L! A0#%     @ W8GE5GY6
M@R;&!   3BP  !4              ( !(0H  &%C:&,M,C R,S V,CA?<')E
M+GAM;%!+ 0(4 Q0    ( -V)Y58Q!.'YC18  #:*   .              "
M 1H/  !D-#,T-3 P9#AK+FAT;5!+ 0(4 Q0    ( -V)Y5;:IGYU[#<  .L'
M 0 1              "  =,E  !D-#,T-3 P9&5X,3 Q+FAT;5!+ 0(4 Q0
M   ( -V)Y5:M+Y,Z#C    K<   1              "  >Y=  !D-#,T-3 P
M9&5X,3 R+FAT;5!+ 0(4 Q0    ( -V)Y5;5D^*HM2<  &6Z   1
M      "  2N.  !D-#,T-3 P9&5X,3 S+FAT;5!+!08     !P ' +X!   /
%M@     !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
